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The	 ﾠuse	 ﾠof	 ﾠnetworks	 ﾠto	 ﾠintegrate	 ﾠdifferent	 ﾠgenetic,	 ﾠproteomic,	 ﾠand	 ﾠmetabolic	 ﾠdatasets	 ﾠhas	 ﾠbeen	 ﾠproposed	 ﾠ
as	 ﾠa	 ﾠviable	 ﾠpath	 ﾠtoward	 ﾠelucidating	 ﾠthe	 ﾠorigins	 ﾠof	 ﾠspecific	 ﾠdiseases.	 ﾠ	 ﾠ
Methodology/Principle	 ﾠFindings	 ﾠ
Here	 ﾠ we	 ﾠ introduce	 ﾠ a	 ﾠ new	 ﾠ phenotypic	 ﾠ database	 ﾠ summarizing	 ﾠ correlations	 ﾠ obtained	 ﾠ from	 ﾠ the	 ﾠ disease	 ﾠ
history	 ﾠof	 ﾠmore	 ﾠthan	 ﾠ30	 ﾠmillion	 ﾠpatients	 ﾠin	 ﾠa	 ﾠPhenotypic	 ﾠDisease	 ﾠNetwork	 ﾠ(PDN).	 ﾠWe	 ﾠpresent	 ﾠevidence	 ﾠ
that	 ﾠthe	 ﾠstructure	 ﾠof	 ﾠthe	 ﾠPDN	 ﾠis	 ﾠrelevant	 ﾠto	 ﾠthe	 ﾠunderstanding	 ﾠof	 ﾠillness	 ﾠprogression	 ﾠby	 ﾠshowing	 ﾠthat	 ﾠ(1)	 ﾠ
patients	 ﾠdevelop	 ﾠdiseases	 ﾠclose	 ﾠin	 ﾠthe	 ﾠnetwork	 ﾠto	 ﾠthose	 ﾠthey	 ﾠalready	 ﾠhave;	 ﾠ(2)	 ﾠthe	 ﾠprogression	 ﾠof	 ﾠdisease	 ﾠ
along	 ﾠthe	 ﾠlinks	 ﾠof	 ﾠthe	 ﾠnetwork	 ﾠis	 ﾠdifferent	 ﾠfor	 ﾠpatients	 ﾠof	 ﾠdifferent	 ﾠgenders	 ﾠand	 ﾠethnicities;	 ﾠ(3)	 ﾠpatients	 ﾠ
diagnosed	 ﾠwith	 ﾠdiseases	 ﾠwhich	 ﾠare	 ﾠmore	 ﾠhighly	 ﾠconnected	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠtend	 ﾠto	 ﾠdie	 ﾠsooner	 ﾠthan	 ﾠthose	 ﾠ
affected	 ﾠby	 ﾠless	 ﾠconnected	 ﾠdiseases;	 ﾠ(4)	 ﾠdiseases	 ﾠthat	 ﾠtend	 ﾠto	 ﾠbe	 ﾠpreceded	 ﾠby	 ﾠothers	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠtend	 ﾠto	 ﾠ
be	 ﾠmore	 ﾠconnected	 ﾠthan	 ﾠdiseases	 ﾠthat	 ﾠprecede	 ﾠother	 ﾠillnesses	 ﾠand	 ﾠare	 ﾠassociated	 ﾠwith	 ﾠhigher	 ﾠdegrees	 ﾠof	 ﾠ
mortality.	 ﾠ
Conclusions/Significance	 ﾠ
Our	 ﾠfindings	 ﾠshow	 ﾠthat	 ﾠdisease	 ﾠprogression	 ﾠcan	 ﾠbe	 ﾠrepresented	 ﾠand	 ﾠstudied	 ﾠusing	 ﾠnetwork	 ﾠmethods,	 ﾠ
offering	 ﾠthe	 ﾠpotential	 ﾠto	 ﾠenhance	 ﾠour	 ﾠunderstanding	 ﾠof	 ﾠthe	 ﾠorigin	 ﾠand	 ﾠevolution	 ﾠof	 ﾠhuman	 ﾠdiseases.	 ﾠThe	 ﾠ
dataset	 ﾠintroduced	 ﾠhere,	 ﾠreleased	 ﾠconcurrently	 ﾠwith	 ﾠthis	 ﾠpublication,	 ﾠrepresents	 ﾠthe	 ﾠlargest	 ﾠrelational	 ﾠ
phenotypic	 ﾠresource	 ﾠpublicly	 ﾠavailable	 ﾠto	 ﾠthe	 ﾠresearch	 ﾠcommunity.	 ﾠ2	 ﾠ
	 ﾠ
Author	 ﾠSummary	 ﾠ
To	 ﾠ help	 ﾠ the	 ﾠ understanding	 ﾠ of	 ﾠ physiological	 ﾠ failures,	 ﾠ diseases	 ﾠ are	 ﾠ defined	 ﾠ as	 ﾠ specific	 ﾠ sets	 ﾠ of	 ﾠ
phenotypes	 ﾠaffecting	 ﾠone	 ﾠor	 ﾠseveral	 ﾠphysiological	 ﾠsystems.	 ﾠYet,	 ﾠthe	 ﾠcomplexity	 ﾠof	 ﾠbiological	 ﾠsystems	 ﾠ
implies	 ﾠthat	 ﾠour	 ﾠworking	 ﾠdefinitions	 ﾠof	 ﾠdiseases	 ﾠare	 ﾠcareful	 ﾠdiscretizations	 ﾠ of	 ﾠa	 ﾠcomplex	 ﾠphenotypic	 ﾠ
space.	 ﾠTo	 ﾠreconcile	 ﾠthe	 ﾠdiscrete	 ﾠnature	 ﾠof	 ﾠdiseases	 ﾠwith	 ﾠthe	 ﾠcomplexity	 ﾠof	 ﾠbiological	 ﾠorganisms,	 ﾠwe	 ﾠneed	 ﾠ
to	 ﾠunderstand	 ﾠhow	 ﾠdiseases	 ﾠare	 ﾠconnected,	 ﾠas	 ﾠconnections	 ﾠbetween	 ﾠthese	 ﾠdifferent	 ﾠdiscrete	 ﾠcategories	 ﾠ
can	 ﾠbe	 ﾠinformative	 ﾠabout	 ﾠthe	 ﾠmechanisms	 ﾠcausing	 ﾠphysiological	 ﾠfailures.	 ﾠ
Here	 ﾠwe	 ﾠintroduce	 ﾠthe	 ﾠPhenotypic	 ﾠDisease	 ﾠNetwork	 ﾠ(PDN)	 ﾠas	 ﾠa	 ﾠmap	 ﾠsummarizing	 ﾠphenotypic	 ﾠ
connections	 ﾠbetween	 ﾠdiseases	 ﾠand	 ﾠshow	 ﾠthat	 ﾠdiseases	 ﾠprogress	 ﾠpreferentially	 ﾠalong	 ﾠthe	 ﾠlinks	 ﾠof	 ﾠthis	 ﾠ
map.	 ﾠFurthermore,	 ﾠwe	 ﾠshow	 ﾠthat	 ﾠthis	 ﾠprogression	 ﾠis	 ﾠdifferent	 ﾠfor	 ﾠpatients	 ﾠwith	 ﾠdifferent	 ﾠgenders	 ﾠand	 ﾠ
racial	 ﾠbackgrounds	 ﾠand	 ﾠthat	 ﾠpatients	 ﾠaffected	 ﾠby	 ﾠdiseases	 ﾠthat	 ﾠare	 ﾠconnected	 ﾠto	 ﾠmany	 ﾠother	 ﾠdiseases	 ﾠin	 ﾠ
the	 ﾠ PDN	 ﾠ tend	 ﾠ to	 ﾠ die	 ﾠ sooner	 ﾠ than	 ﾠ those	 ﾠ affected	 ﾠ by	 ﾠ less	 ﾠ connected	 ﾠ diseases.	 ﾠAdditionally,	 ﾠwe	 ﾠhave	 ﾠ
created	 ﾠa	 ﾠqueryable	 ﾠonline	 ﾠdatabase	 ﾠ(http://hudine.neu.edu)	 ﾠof	 ﾠthe	 ﾠ18	 ﾠdifferent	 ﾠdatasets	 ﾠgenerated	 ﾠ
from	 ﾠthe	 ﾠmore	 ﾠthan	 ﾠ31	 ﾠmillion	 ﾠpatients	 ﾠin	 ﾠthis	 ﾠstudy.	 ﾠThe	 ﾠdisease	 ﾠassociations	 ﾠcan	 ﾠbe	 ﾠexplored	 ﾠonline	 ﾠor	 ﾠ





There	 ﾠare	 ﾠno	 ﾠclear	 ﾠboundaries	 ﾠbetween	 ﾠmany	 ﾠdiseases,	 ﾠas	 ﾠdiseases	 ﾠcan	 ﾠhave	 ﾠmultiple	 ﾠcauses	 ﾠand	 ﾠ
can	 ﾠbe	 ﾠrelated	 ﾠthrough	 ﾠseveral	 ﾠdimensions.	 ﾠFrom	 ﾠa	 ﾠgenetic	 ﾠperspective,	 ﾠa	 ﾠpair	 ﾠof	 ﾠdiseases	 ﾠcan	 ﾠbe	 ﾠrelated	 ﾠ
because	 ﾠ they	 ﾠ have	 ﾠ both	 ﾠ been	 ﾠ associated	 ﾠ with	 ﾠ the	 ﾠ same	 ﾠ gene	 ﾠ [1,2],	 ﾠ whereas	 ﾠ from	 ﾠ a	 ﾠ proteomic	 ﾠ
perspective	 ﾠdiseases	 ﾠcan	 ﾠbe	 ﾠrelated	 ﾠbecause	 ﾠdisease	 ﾠassociated	 ﾠproteins	 ﾠact	 ﾠon	 ﾠthe	 ﾠsame	 ﾠpathway	 ﾠ[3-ﾭ‐9].	 ﾠ
During	 ﾠthe	 ﾠpast	 ﾠhalf-ﾭ‐decade,	 ﾠseveral	 ﾠresources	 ﾠhave	 ﾠbeen	 ﾠconstructed	 ﾠto	 ﾠhelp	 ﾠunderstand	 ﾠthe	 ﾠ
entangled	 ﾠorigins	 ﾠof	 ﾠmany	 ﾠdiseases.	 ﾠMany	 ﾠof	 ﾠthese	 ﾠresources	 ﾠhave	 ﾠbeen	 ﾠpresented	 ﾠas	 ﾠnetworks	 ﾠin	 ﾠwhich	 ﾠ
interactions	 ﾠ between	 ﾠ disease-ﾭ‐associated	 ﾠ genes,	 ﾠ proteins,	 ﾠ and	 ﾠ expression	 ﾠ patterns	 ﾠ have	 ﾠ been	 ﾠ
summarized.	 ﾠFor	 ﾠexample,	 ﾠGoh	 ﾠet	 ﾠal.	 ﾠcreated	 ﾠa	 ﾠnetwork	 ﾠof	 ﾠMendelian	 ﾠgene-ﾭ‐disease	 ﾠassociations	 ﾠby	 ﾠ
connecting	 ﾠdiseases	 ﾠthat	 ﾠhave	 ﾠbeen	 ﾠassociated	 ﾠwith	 ﾠthe	 ﾠsame	 ﾠgenes	 ﾠ[1]	 ﾠ(see	 ﾠalso	 ﾠFeldman	 ﾠet	 ﾠal.	 ﾠ[2]),	 ﾠ
whereas	 ﾠ Lee	 ﾠ et	 ﾠ al.	 ﾠ constructed	 ﾠ a	 ﾠ network	 ﾠ in	 ﾠ which	 ﾠ two	 ﾠ diseases	 ﾠ are	 ﾠ linked	 ﾠ if	 ﾠ mutated	 ﾠ enzymes	 ﾠ
associated	 ﾠwith	 ﾠthem	 ﾠcatalyze	 ﾠadjacent	 ﾠmetabolic	 ﾠreactions	 ﾠ[10].	 ﾠNetwork	 ﾠstudies	 ﾠin	 ﾠthe	 ﾠproteomic	 ﾠfront	 ﾠ
have	 ﾠstudied	 ﾠlarge	 ﾠprotein	 ﾠinteraction	 ﾠnetworks,	 ﾠlike	 ﾠthe	 ﾠones	 ﾠcreated	 ﾠby	 ﾠRual	 ﾠet	 ﾠal.	 ﾠ[3]	 ﾠand	 ﾠStelzl	 ﾠet	 ﾠal.	 ﾠ
[4],	 ﾠ in	 ﾠ an	 ﾠ attempt	 ﾠ to	 ﾠ understand	 ﾠd i s e a s e s 	 ﾠl i k e 	 ﾠi n h e r i t e d 	 ﾠa t a xias	 ﾠ [5]	 ﾠ or	 ﾠ Huntington’s	 ﾠ disease	 ﾠ [6].	 ﾠ
Moreover,	 ﾠ in	 ﾠ the	 ﾠ gene	 ﾠ expression	 ﾠ front,	 ﾠ microarray	 ﾠ expression	 ﾠ profiles	 ﾠ and	 ﾠ other	 ﾠ cellular	 ﾠ level	 ﾠ
information	 ﾠ have	 ﾠ been	 ﾠ used	 ﾠ to	 ﾠ explore	 ﾠ networks	 ﾠ in	 ﾠ inflammation	 ﾠ [7],	 ﾠ breast	 ﾠ cancer	 ﾠ [8],	 ﾠ and	 ﾠ brain	 ﾠ
disease	 ﾠ[9].	 ﾠ
While	 ﾠprogress	 ﾠon	 ﾠthe	 ﾠgenetic	 ﾠand	 ﾠproteomic	 ﾠfronts	 ﾠhas	 ﾠbeen	 ﾠimpressive	 ﾠ[1,10],	 ﾠmuch	 ﾠof	 ﾠthe	 ﾠ
available	 ﾠ resources	 ﾠ overlook	 ﾠ the	 ﾠ fact	 ﾠ that	 ﾠ we	 ﾠ have	 ﾠ extensive	 ﾠ and	 ﾠ continually	 ﾠ updated	 ﾠ phenotypic	 ﾠ
information	 ﾠfor	 ﾠhumans	 ﾠ–	 ﾠnamely,	 ﾠpatient	 ﾠclinical	 ﾠhistories.	 ﾠIndeed,	 ﾠhospitals	 ﾠand	 ﾠinsurance	 ﾠprograms	 ﾠ
constantly	 ﾠ collect	 ﾠ detailed	 ﾠ records	 ﾠ for	 ﾠ millions	 ﾠ of	 ﾠ patients.	 ﾠ These	 ﾠ datasets	 ﾠ contain	 ﾠ information	 ﾠ on	 ﾠ
disease	 ﾠassociations	 ﾠand	 ﾠprogression.	 ﾠFor	 ﾠexample,	 ﾠsuch	 ﾠpopulation-ﾭ‐based	 ﾠdisease	 ﾠassociations	 ﾠcould	 ﾠbe	 ﾠ4	 ﾠ
	 ﾠ
used	 ﾠ in	 ﾠ conjunction	 ﾠ with	 ﾠ molecular	 ﾠ and	 ﾠ genetic	 ﾠ data	 ﾠ to	 ﾠ help	 ﾠ us	 ﾠ uncover	 ﾠ the	 ﾠ molecular	 ﾠ origins	 ﾠ of	 ﾠ
diseases.	 ﾠ Despite	 ﾠ the	 ﾠ potential	 ﾠ utility	 ﾠ of	 ﾠ population	 ﾠ based	 ﾠ disease	 ﾠ associations,	 ﾠ extensive	 ﾠ datasets	 ﾠ
linking	 ﾠ diseases	 ﾠ based	 ﾠ on	 ﾠ comorbidity	 ﾠ associations	 ﾠ do	 ﾠ not	 ﾠ exist,	 ﾠ partly	 ﾠ because	 ﾠ access	 ﾠ to	 ﾠ extensive	 ﾠ
medical	 ﾠrecords	 ﾠis	 ﾠlimited.	 ﾠ	 ﾠ
Typically,	 ﾠwe	 ﾠsay	 ﾠthat	 ﾠa	 ﾠcomorbidity	 ﾠrelationship	 ﾠexists	 ﾠbetween	 ﾠtwo	 ﾠdiseases	 ﾠwhenever	 ﾠthey	 ﾠ
affect	 ﾠthe	 ﾠsame	 ﾠindividual	 ﾠsubstantially	 ﾠmore	 ﾠthan	 ﾠchance	 ﾠalone.	 ﾠOne	 ﾠof	 ﾠour	 ﾠprimary	 ﾠgoals	 ﾠhere	 ﾠis	 ﾠto	 ﾠ
make	 ﾠavailable	 ﾠpairwise	 ﾠcomorbidity	 ﾠcorrelations	 ﾠfor	 ﾠmore	 ﾠthan	 ﾠ10	 ﾠthousand	 ﾠdiseases	 ﾠreconstructed	 ﾠ
from	 ﾠ over	 ﾠ 30	 ﾠ million	 ﾠ medical	 ﾠ records.	 ﾠ For	 ﾠ completeness	 ﾠ and	 ﾠ utility,	 ﾠ we	 ﾠ organize	 ﾠ the	 ﾠ results	 ﾠ in	 ﾠ 18	 ﾠ
different	 ﾠdatasets.	 ﾠEach	 ﾠsummarizes	 ﾠphenotypic	 ﾠassociations	 ﾠextracted	 ﾠfrom	 ﾠfour	 ﾠyears	 ﾠworth	 ﾠof	 ﾠICD9-ﾭ‐
CM	 ﾠclaims	 ﾠdata	 ﾠat	 ﾠthe	 ﾠ5	 ﾠand	 ﾠ3	 ﾠdigit	 ﾠlevel.	 ﾠResults	 ﾠare	 ﾠgrouped	 ﾠinto	 ﾠsubsets	 ﾠof	 ﾠrace,	 ﾠgender,	 ﾠand	 ﾠboth	 ﾠrace	 ﾠ
and	 ﾠ gender	 ﾠ (see	 ﾠ SM).	 ﾠ To	 ﾠ facilitate	 ﾠ their	 ﾠ use,	 ﾠ the	 ﾠ datasets	 ﾠ are	 ﾠ available	 ﾠ as	 ﾠ a	 ﾠ bulk	 ﾠ download	 ﾠ
(http://hudine.neu.edu/resource/data/data.html	 ﾠ) 	 ﾠo r 	 ﾠt h r o u g h 	 ﾠa 	 ﾠs e a r c h a b l e 	 ﾠw e b 	 ﾠi n t e r f a c e 	 ﾠ
(http://hudine.neu.edu)	 ﾠthat	 ﾠallows	 ﾠresearchers,	 ﾠdoctors	 ﾠand	 ﾠpatients	 ﾠto	 ﾠexplore	 ﾠthese	 ﾠdisease	 ﾠnetworks	 ﾠ
graphically,	 ﾠthrough	 ﾠan	 ﾠinteractive	 ﾠFlash	 ﾠapplication,	 ﾠand	 ﾠnumerically,	 ﾠby	 ﾠallowing	 ﾠthem	 ﾠto	 ﾠgenerate	 ﾠ
tables	 ﾠsummarizing	 ﾠthe	 ﾠassociations	 ﾠbetween	 ﾠa	 ﾠparticular	 ﾠdisease	 ﾠand	 ﾠall	 ﾠother	 ﾠdiseases.	 ﾠ
	 ﾠ In	 ﾠthe	 ﾠpast,	 ﾠcomorbidities	 ﾠhave	 ﾠbeen	 ﾠused	 ﾠextensively	 ﾠto	 ﾠconstruct	 ﾠsynthetic	 ﾠscales	 ﾠfor	 ﾠmortality	 ﾠ
prediction	 ﾠ[11,12],	 ﾠyet	 ﾠtheir	 ﾠutility	 ﾠcould	 ﾠexceed	 ﾠtheir	 ﾠcurrent	 ﾠuse.	 ﾠStudying	 ﾠthe	 ﾠstructure	 ﾠdefined	 ﾠby	 ﾠ
entire	 ﾠsets	 ﾠof	 ﾠcomorbidities	 ﾠmight	 ﾠhelp	 ﾠthe	 ﾠunderstanding	 ﾠof	 ﾠmany	 ﾠbiological	 ﾠand	 ﾠmedical	 ﾠquestions	 ﾠ
from	 ﾠa	 ﾠperspective	 ﾠthat	 ﾠis	 ﾠcomplementary	 ﾠto	 ﾠother	 ﾠapproaches.	 ﾠFor	 ﾠexample,	 ﾠa	 ﾠrecent	 ﾠstudy	 ﾠbuilt	 ﾠa	 ﾠ
comorbidity	 ﾠnetwork	 ﾠin	 ﾠan	 ﾠattempt	 ﾠto	 ﾠelucidate	 ﾠneurological	 ﾠdiseases	 ﾠcommon	 ﾠgenetic	 ﾠorigins	 ﾠ[13].	 ﾠ
Heretofore,	 ﾠhowever,	 ﾠneither	 ﾠthis	 ﾠdata	 ﾠnor	 ﾠthe	 ﾠdata	 ﾠnecessary	 ﾠto	 ﾠexplore	 ﾠrelationships	 ﾠbetween	 ﾠall	 ﾠ
diseases	 ﾠis	 ﾠcurrently	 ﾠavailable	 ﾠto	 ﾠthe	 ﾠresearch	 ﾠcommunity.	 ﾠHence,	 ﾠhere	 ﾠwe	 ﾠdecide	 ﾠto	 ﾠprovide	 ﾠthis	 ﾠdata	 ﾠin	 ﾠ
the	 ﾠform	 ﾠof	 ﾠa	 ﾠPhenotypic	 ﾠDisease	 ﾠNetwork	 ﾠ(PDN)	 ﾠcapturing	 ﾠall	 ﾠdiseases	 ﾠas	 ﾠrecorded	 ﾠthrough	 ﾠmedical	 ﾠ5	 ﾠ
	 ﾠ
claims.	 ﾠAdditionally,	 ﾠwe	 ﾠillustrate	 ﾠhow	 ﾠa	 ﾠPDN	 ﾠcan	 ﾠbe	 ﾠused	 ﾠto	 ﾠstudy	 ﾠillness	 ﾠprogression	 ﾠfrom	 ﾠa	 ﾠdynamic	 ﾠ
network	 ﾠperspective	 ﾠby	 ﾠinterpreting	 ﾠthe	 ﾠPDN	 ﾠas	 ﾠthe	 ﾠlandscape	 ﾠwhere	 ﾠillness	 ﾠprogression	 ﾠoccurs	 ﾠand	 ﾠ
show	 ﾠhow	 ﾠthe	 ﾠnetwork	 ﾠcan	 ﾠbe	 ﾠused	 ﾠto	 ﾠstudy	 ﾠphenotypic	 ﾠdifferences	 ﾠbetween	 ﾠpatients	 ﾠwith	 ﾠdifferent	 ﾠ
demographic	 ﾠbackgrounds.	 ﾠFurthermore,	 ﾠwe	 ﾠshow	 ﾠthat	 ﾠthe	 ﾠlocal	 ﾠstructure	 ﾠof	 ﾠa	 ﾠdisease	 ﾠin	 ﾠthe	 ﾠnetwork,	 ﾠ
as	 ﾠcharacterized	 ﾠby	 ﾠits	 ﾠdegree	 ﾠor	 ﾠnumber	 ﾠof	 ﾠconnections,	 ﾠis	 ﾠassociated	 ﾠwith	 ﾠdisease	 ﾠmortality.	 ﾠFinally,	 ﾠwe	 ﾠ
study	 ﾠthe	 ﾠdirectionality	 ﾠof	 ﾠdisease	 ﾠprogression,	 ﾠas	 ﾠobserved	 ﾠin	 ﾠour	 ﾠdataset,	 ﾠand	 ﾠfind	 ﾠthat	 ﾠmore	 ﾠcentral	 ﾠ
diseases	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠare	 ﾠmore	 ﾠlikely	 ﾠto	 ﾠoccur	 ﾠafter	 ﾠother	 ﾠdiseases	 ﾠand	 ﾠthat	 ﾠmore	 ﾠperipheral	 ﾠdiseases	 ﾠtend	 ﾠ
to	 ﾠprecede	 ﾠother	 ﾠillnesses.	 ﾠWe	 ﾠalso	 ﾠfind	 ﾠthat	 ﾠpatients	 ﾠdiagnosed	 ﾠwith	 ﾠdiseases	 ﾠthat	 ﾠtend	 ﾠto	 ﾠbe	 ﾠpreceded	 ﾠ
by	 ﾠother	 ﾠconditions	 ﾠtend	 ﾠto	 ﾠdie	 ﾠsooner	 ﾠthan	 ﾠthose	 ﾠdiagnosed	 ﾠwith	 ﾠconditions	 ﾠthat	 ﾠtend	 ﾠto	 ﾠprecede	 ﾠother	 ﾠ
diseases.	 ﾠTogether,	 ﾠthese	 ﾠresults	 ﾠand	 ﾠresources	 ﾠopen	 ﾠnew	 ﾠopportunities	 ﾠfor	 ﾠbiomolecular,	 ﾠbioinformatic	 ﾠ
and	 ﾠpublic	 ﾠhealth	 ﾠapproaches	 ﾠto	 ﾠdisease.	 ﾠ	 ﾠ
METHODS	 ﾠ
Source	 ﾠData	 ﾠand	 ﾠStudy	 ﾠPopulation:	 ﾠ
Hospital	 ﾠclaims	 ﾠoffer	 ﾠreliable,	 ﾠsystematic,	 ﾠand	 ﾠcomplete	 ﾠdata	 ﾠfor	 ﾠdisease	 ﾠdetection	 ﾠ[14,15,16].	 ﾠ
Each	 ﾠrecord	 ﾠconsists	 ﾠof	 ﾠthe	 ﾠdate	 ﾠof	 ﾠvisit,	 ﾠa	 ﾠprimary	 ﾠdiagnosis	 ﾠand	 ﾠup	 ﾠto	 ﾠ9	 ﾠsecondary	 ﾠdiagnoses,	 ﾠall	 ﾠ
specified	 ﾠby	 ﾠICD9	 ﾠcodes	 ﾠof	 ﾠup	 ﾠto	 ﾠ5	 ﾠdigits.	 ﾠThe	 ﾠfirst	 ﾠthree	 ﾠdigits	 ﾠspecify	 ﾠthe	 ﾠmain	 ﾠdisease	 ﾠcategory	 ﾠwhile	 ﾠ
the	 ﾠ last	 ﾠ two	 ﾠ provide	 ﾠ additional	 ﾠ information	 ﾠ about	 ﾠ the	 ﾠ disease.	 ﾠ In	 ﾠ total,	 ﾠ the	 ﾠ ICD-ﾭ‐9-ﾭ‐CM	 ﾠ classification	 ﾠ
consists	 ﾠof	 ﾠ657	 ﾠdifferent	 ﾠcategories	 ﾠat	 ﾠthe	 ﾠ3	 ﾠdigit	 ﾠlevel	 ﾠand	 ﾠ16,459	 ﾠcategories	 ﾠat	 ﾠ5	 ﾠdigits.	 ﾠFor	 ﾠa	 ﾠdetailed	 ﾠ
list	 ﾠof	 ﾠcurrently	 ﾠused	 ﾠICD9	 ﾠcodes	 ﾠsee	 ﾠwww.icd9data.com.	 ﾠWe	 ﾠcompiled	 ﾠraw	 ﾠMedicare	 ﾠclaims	 ﾠ[17,18]	 ﾠ
based	 ﾠ on	 ﾠ so-ﾭ‐called	 ﾠ MedPAR	 ﾠ records	 ﾠ regarding	 ﾠ hospitalizations	 ﾠ for	 ﾠ 1990-ﾭ‐1993.	 ﾠ Medicare	 ﾠ is	 ﾠ the	 ﾠ US	 ﾠ
government’s	 ﾠhealth	 ﾠinsurer,	 ﾠand	 ﾠit	 ﾠhas	 ﾠinformation	 ﾠon	 ﾠ96%	 ﾠof	 ﾠall	 ﾠelderly	 ﾠAmericans	 ﾠwhether	 ﾠthey	 ﾠseek	 ﾠ
medical	 ﾠcare	 ﾠor	 ﾠnot	 ﾠ[19].	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For	 ﾠthe	 ﾠ32	 ﾠmillion	 ﾠelderly	 ﾠAmericans	 ﾠaged	 ﾠ65	 ﾠor	 ﾠolder	 ﾠenrolled	 ﾠin	 ﾠMedicare	 ﾠand	 ﾠalive	 ﾠfor	 ﾠthe	 ﾠ
entire	 ﾠ study	 ﾠ period,	 ﾠ there	 ﾠ were	 ﾠ a	 ﾠ total	 ﾠ of	 ﾠ 32,341,347	 ﾠ inpatient	 ﾠ claims,	 ﾠ pertaining	 ﾠ to	 ﾠ 13,039,018	 ﾠ
individuals	 ﾠ (the	 ﾠ remaining	 ﾠ individuals	 ﾠ were	 ﾠ not	 ﾠ hospitalized	 ﾠ at	 ﾠ any	 ﾠ point	 ﾠ during	 ﾠ this	 ﾠ period).	 ﾠ
Demographically,	 ﾠour	 ﾠdata	 ﾠset	 ﾠconsists	 ﾠof	 ﾠpatients	 ﾠover	 ﾠ65	 ﾠyears	 ﾠold	 ﾠ(see	 ﾠFig	 ﾠ1A	 ﾠfor	 ﾠthe	 ﾠage	 ﾠdistribution)	 ﾠ
and	 ﾠis	 ﾠcomposed	 ﾠmainly	 ﾠof	 ﾠwhite	 ﾠpatients,	 ﾠwith	 ﾠa	 ﾠhigher	 ﾠpercentage	 ﾠof	 ﾠfemales	 ﾠ(58.3%	 ﾠFig	 ﾠ1B).	 ﾠYet,	 ﾠthe	 ﾠ
data	 ﾠset	 ﾠis	 ﾠlarge	 ﾠenough	 ﾠto	 ﾠestimate	 ﾠrace	 ﾠand	 ﾠgender	 ﾠspecific	 ﾠcomorbidity	 ﾠpatterns.	 ﾠ
	 ﾠ
Data	 ﾠLimitations	 ﾠ
The	 ﾠ medical	 ﾠ claims	 ﾠ were	 ﾠ made	 ﾠ available	 ﾠ to	 ﾠ us	 ﾠ is	 ﾠ in	 ﾠ the	 ﾠ ICD-ﾭ‐9-ﾭ‐CM	 ﾠ format,	 ﾠ representing	 ﾠ a	 ﾠ
controlled	 ﾠnomenclature	 ﾠconstructed	 ﾠmainly	 ﾠfor	 ﾠinsurance	 ﾠclaim	 ﾠpurposes.	 ﾠTherefore,	 ﾠin	 ﾠsome	 ﾠcases,	 ﾠ
more	 ﾠthan	 ﾠone	 ﾠcode	 ﾠcorresponds	 ﾠto	 ﾠa	 ﾠparticular	 ﾠdisease,	 ﾠwhereas	 ﾠin	 ﾠother	 ﾠcases	 ﾠcodes	 ﾠare	 ﾠnot	 ﾠspecific	 ﾠ
enough	 ﾠfor	 ﾠresearch	 ﾠpurposes.	 ﾠFor	 ﾠexample,	 ﾠat	 ﾠthe	 ﾠ5-ﾭ‐digit	 ﾠlevel	 ﾠthere	 ﾠare	 ﾠ33	 ﾠdiagnoses	 ﾠassociated	 ﾠwith	 ﾠ
hypertension,	 ﾠwhich	 ﾠreduce	 ﾠto	 ﾠfive	 ﾠat	 ﾠthe	 ﾠ3-ﾭ‐digit	 ﾠlevel.	 ﾠOther	 ﾠtimes,	 ﾠthe	 ﾠcode	 ﾠis	 ﾠfor	 ﾠa	 ﾠsymptom	 ﾠsuch	 ﾠas	 ﾠ
“dehydration”	 ﾠwhich	 ﾠcannot	 ﾠbe	 ﾠassigned	 ﾠto	 ﾠany	 ﾠone	 ﾠdiagnosis.	 ﾠThe	 ﾠvast	 ﾠmajority	 ﾠof	 ﾠdiseases,	 ﾠhowever,	 ﾠ
do	 ﾠmap	 ﾠreliably	 ﾠto	 ﾠICD9	 ﾠcodes.	 ﾠ	 ﾠ
While	 ﾠhospital	 ﾠclaims	 ﾠhave	 ﾠbeen	 ﾠproposed	 ﾠas	 ﾠa	 ﾠreliable	 ﾠmethod	 ﾠfor	 ﾠdisease	 ﾠdetection	 ﾠ[15,16,20],	 ﾠ
our	 ﾠdata	 ﾠdoes	 ﾠnot	 ﾠcapture	 ﾠa	 ﾠcomplete	 ﾠcross	 ﾠsection	 ﾠof	 ﾠthe	 ﾠpopulation.	 ﾠOur	 ﾠdataset	 ﾠconsists	 ﾠof	 ﾠmedical	 ﾠ
claims	 ﾠassociated	 ﾠwith	 ﾠhospitalizations	 ﾠof	 ﾠelderly	 ﾠcitizens	 ﾠin	 ﾠthe	 ﾠUnited	 ﾠStates;	 ﾠthus,	 ﾠit	 ﾠcontains	 ﾠlimited	 ﾠ
information	 ﾠabout	 ﾠdiseases	 ﾠthat	 ﾠare	 ﾠnot	 ﾠcommon	 ﾠamong	 ﾠelders	 ﾠfrom	 ﾠan	 ﾠindustrialized	 ﾠcountry,	 ﾠsuch	 ﾠas	 ﾠ
many	 ﾠinfectious	 ﾠdiseases	 ﾠor	 ﾠpregnancy-ﾭ‐related	 ﾠconditions.	 ﾠNor	 ﾠdoes	 ﾠit	 ﾠcontain	 ﾠinformation	 ﾠon	 ﾠpatients	 ﾠ
who	 ﾠ were	 ﾠ not	 ﾠ hospitalized	 ﾠ and	 ﾠ who	 ﾠ instead	 ﾠ seek	 ﾠ solely	 ﾠ outpatient	 ﾠ care.	 ﾠ Hence,	 ﾠ it	 ﾠ is	 ﾠ important	 ﾠ to	 ﾠ
interpret	 ﾠour	 ﾠresults	 ﾠin	 ﾠthe	 ﾠcontext	 ﾠof	 ﾠa	 ﾠpopulation	 ﾠof	 ﾠelderly	 ﾠcitizens	 ﾠin	 ﾠan	 ﾠindustrialized	 ﾠcountry.	 ﾠ	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Quantifying	 ﾠthe	 ﾠStrength	 ﾠof	 ﾠComorbidity	 ﾠRelationships	 ﾠ
To	 ﾠmeasure	 ﾠrelatedness	 ﾠstarting	 ﾠfrom	 ﾠdisease	 ﾠco-ﾭ‐occurrence,	 ﾠwe	 ﾠneed	 ﾠto	 ﾠquantify	 ﾠthe	 ﾠstrength	 ﾠ
of	 ﾠcomorbidities	 ﾠby	 ﾠintroducing	 ﾠa	 ﾠnotion	 ﾠof	 ﾠ“distance”	 ﾠbetween	 ﾠtwo	 ﾠdiseases	 ﾠ(see	 ﾠText	 ﾠS1).	 ﾠA	 ﾠdifficulty	 ﾠof	 ﾠ
this	 ﾠapproach	 ﾠis	 ﾠthat	 ﾠdifferent	 ﾠstatistical	 ﾠdistance	 ﾠmeasures	 ﾠhave	 ﾠbiases	 ﾠthat	 ﾠover-ﾭ‐	 ﾠor	 ﾠunder-ﾭ‐estimate	 ﾠthe	 ﾠ
relationships	 ﾠbetween	 ﾠrare	 ﾠor	 ﾠprevalent	 ﾠdiseases.	 ﾠThese	 ﾠbiases	 ﾠare	 ﾠimportant	 ﾠgiven	 ﾠthat	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠ
times	 ﾠa	 ﾠparticular	 ﾠdisease	 ﾠis	 ﾠdiagnosed	 ﾠ–its	 ﾠprevalence-ﾭ‐	 ﾠfollows	 ﾠa	 ﾠheavy	 ﾠtailed	 ﾠdistribution	 ﾠ(Fig	 ﾠ1	 ﾠC),	 ﾠ
meaning	 ﾠthat	 ﾠwhile	 ﾠmost	 ﾠdiseases	 ﾠare	 ﾠrarely	 ﾠdiagnosed,	 ﾠa	 ﾠfew	 ﾠdiseases	 ﾠhave	 ﾠbeen	 ﾠdiagnosed	 ﾠin	 ﾠa	 ﾠlarge	 ﾠ
fraction	 ﾠ of	 ﾠ the	 ﾠ population.	 ﾠ Hence,	 ﾠ quantifying	 ﾠ comorbidity	 ﾠ often	 ﾠ requires	 ﾠ us	 ﾠt o 	 ﾠc o m p a r e 	 ﾠd i s e a s e s 	 ﾠ
affecting	 ﾠa	 ﾠfew	 ﾠdozen	 ﾠpatients	 ﾠwith	 ﾠdiseases	 ﾠaffecting	 ﾠmillions.	 ﾠ
We	 ﾠwill	 ﾠuse	 ﾠtwo	 ﾠcomorbidity	 ﾠmeasures	 ﾠto	 ﾠquantify	 ﾠthe	 ﾠdistance	 ﾠbetween	 ﾠtwo	 ﾠdiseases:	 ﾠThe	 ﾠ
Relative	 ﾠRisk	 ﾠ(RR)	 ﾠand	 ﾠφ-ﾭ‐correlation	 ﾠ(φ).	 ﾠThe	 ﾠRR	 ﾠof	 ﾠobserving	 ﾠa	 ﾠpair	 ﾠof	 ﾠdiseases	 ﾠi	 ﾠand	 ﾠj	 ﾠaffecting	 ﾠthe	 ﾠsame	 ﾠ
patient	 ﾠis	 ﾠgiven	 ﾠby	 ﾠ
   
(1)  
where	 ﾠCij	 ﾠis	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠpatients	 ﾠaffected	 ﾠby	 ﾠboth	 ﾠdiseases,	 ﾠN	 ﾠis	 ﾠthe	 ﾠtotal	 ﾠnumber	 ﾠof	 ﾠpatients	 ﾠin	 ﾠthe	 ﾠ
population	 ﾠand	 ﾠPi	 ﾠand	 ﾠPj	 ﾠare	 ﾠthe	 ﾠprevalences	 ﾠof	 ﾠdiseases	 ﾠi	 ﾠand	 ﾠj.	 ﾠThe	 ﾠdistribution	 ﾠof	 ﾠRR	 ﾠvalues	 ﾠfound	 ﾠin	 ﾠ
our	 ﾠdata	 ﾠset	 ﾠis	 ﾠshown	 ﾠin	 ﾠFig	 ﾠ1	 ﾠD.	 ﾠThe	 ﾠφ-ﾭ‐correlation,	 ﾠwhich	 ﾠis	 ﾠPearson’s	 ﾠcorrelation	 ﾠfor	 ﾠbinary	 ﾠvariables,	 ﾠ
can	 ﾠbe	 ﾠexpressed	 ﾠmathematically	 ﾠas:	 ﾠ
   
(2)  
The	 ﾠdistribution	 ﾠof	 ﾠφ	 ﾠvalues	 ﾠrepresenting	 ﾠall	 ﾠdisease	 ﾠpairs	 ﾠwhere	 ﾠCij>0	 ﾠis	 ﾠpresented	 ﾠin	 ﾠFig	 ﾠ1	 ﾠE.	 ﾠA	 ﾠdiscussion	 ﾠ
on	 ﾠthe	 ﾠconfidence	 ﾠinterval	 ﾠand	 ﾠstatistical	 ﾠsignificance	 ﾠof	 ﾠthese	 ﾠmeasures	 ﾠcan	 ﾠbe	 ﾠfound	 ﾠin	 ﾠthe	 ﾠText	 ﾠS1.	 ﾠ	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These	 ﾠtwo	 ﾠcomorbidity	 ﾠmeasures	 ﾠare	 ﾠnot	 ﾠcompletely	 ﾠindependent	 ﾠof	 ﾠeach	 ﾠother	 ﾠ(Fig	 ﾠ1	 ﾠF),	 ﾠas	 ﾠ
they	 ﾠboth	 ﾠincrease	 ﾠwith	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠpatients	 ﾠaffected	 ﾠby	 ﾠboth	 ﾠdiseases,	 ﾠyet	 ﾠboth	 ﾠmeasures	 ﾠhave	 ﾠtheir	 ﾠ
intrinsic	 ﾠbiases.	 ﾠFor	 ﾠexample,	 ﾠRR	 ﾠoverestimates	 ﾠrelationships	 ﾠinvolving	 ﾠrare	 ﾠdiseases	 ﾠand	 ﾠunderestimates	 ﾠ
the	 ﾠcomorbidity	 ﾠbetween	 ﾠhighly	 ﾠprevalent	 ﾠillnesses,	 ﾠwhereas	 ﾠφ	 ﾠaccurately	 ﾠdiscriminates	 ﾠcomorbidities	 ﾠ
between	 ﾠpairs	 ﾠof	 ﾠdiseases	 ﾠof	 ﾠsimilar	 ﾠprevalence	 ﾠbut	 ﾠunderestimates	 ﾠthe	 ﾠcomorbidity	 ﾠbetween	 ﾠrare	 ﾠand	 ﾠ
common	 ﾠdiseases	 ﾠ(see	 ﾠSM	 ﾠBox	 ﾠ1).	 ﾠGiven	 ﾠthe	 ﾠcomplementary	 ﾠbiases	 ﾠof	 ﾠthe	 ﾠtwo	 ﾠmeasures,	 ﾠwe	 ﾠconstruct	 ﾠa	 ﾠ
PDN	 ﾠseparately	 ﾠfor	 ﾠeach	 ﾠmeasure	 ﾠand	 ﾠdiscuss	 ﾠtheir	 ﾠrespective	 ﾠrelevance	 ﾠto	 ﾠspecific	 ﾠdisease	 ﾠgroups.	 ﾠ
One	 ﾠ important	 ﾠ question	 ﾠ is	 ﾠ how	 ﾠ the	 ﾠ predictive	 ﾠ power	 ﾠ of	 ﾠ comorbidity	 ﾠ based	 ﾠ relationships	 ﾠ
compares	 ﾠwith	 ﾠthat	 ﾠof	 ﾠheredity	 ﾠand	 ﾠknown	 ﾠgenetic	 ﾠmarkers.	 ﾠOf	 ﾠthe	 ﾠtwo	 ﾠmeasures	 ﾠdiscussed	 ﾠabove,	 ﾠthe	 ﾠ
Relative	 ﾠRisk	 ﾠ(RR)	 ﾠenjoys	 ﾠthe	 ﾠmost	 ﾠwidespread	 ﾠuse	 ﾠin	 ﾠthe	 ﾠmedical	 ﾠliterature	 ﾠ[21-ﾭ‐30],	 ﾠmaking	 ﾠit	 ﾠthe	 ﾠmost	 ﾠ
suitable	 ﾠfor	 ﾠsuch	 ﾠcomparison.	 ﾠ	 ﾠWe	 ﾠfind	 ﾠthat	 ﾠthe	 ﾠrelative	 ﾠrisk	 ﾠof	 ﾠbeing	 ﾠdiagnosed	 ﾠwith	 ﾠone	 ﾠdisease	 ﾠgiven	 ﾠ
another	 ﾠdisease	 ﾠaffecting	 ﾠa	 ﾠpatient	 ﾠin	 ﾠour	 ﾠdata	 ﾠvaries	 ﾠin	 ﾠthe	 ﾠrange	 ﾠRR∼0.25-ﾭ‐16	 ﾠ(Fig	 ﾠ1	 ﾠD).	 ﾠSibling	 ﾠstudies	 ﾠ
have	 ﾠfound	 ﾠthat	 ﾠthe	 ﾠrelative	 ﾠrisk	 ﾠof	 ﾠhaving	 ﾠa	 ﾠdisease	 ﾠgiven	 ﾠthat	 ﾠa	 ﾠsibling	 ﾠhas	 ﾠthe	 ﾠsame	 ﾠdisease	 ﾠtypically	 ﾠ
ranges	 ﾠfrom	 ﾠRR∼3 for	 ﾠtype	 ﾠ2	 ﾠdiabetes	 ﾠ[21]	 ﾠto	 ﾠRR∼2-ﾭ‐7	 ﾠfor	 ﾠearly	 ﾠmyocardial	 ﾠinfarction	 ﾠ[22],	 ﾠ∼7-ﾭ‐10	 ﾠfor	 ﾠ
bipolar	 ﾠdisorder	 ﾠ[23,24]	 ﾠand	 ﾠrheumatoid	 ﾠarthritis	 ﾠ[25]	 ﾠand	 ﾠ∼17-ﾭ‐35	 ﾠfor	 ﾠCrohn’s	 ﾠDisease	 ﾠ[26].	 ﾠMost	 ﾠof	 ﾠ
these	 ﾠ values	 ﾠ fall	 ﾠ in	 ﾠ the	 ﾠ range	 ﾠ of	 ﾠ relative	 ﾠ risks	 ﾠ associated	 ﾠ with	 ﾠ our	 ﾠ observed	 ﾠ comorbidities.	 ﾠ Hence,	 ﾠ
statistically	 ﾠ speaking,	 ﾠ the	 ﾠ magnitude	 ﾠ of	 ﾠ the	 ﾠ disease	 ﾠ risk	 ﾠ predicted	 ﾠ by	 ﾠ comorbidity	 ﾠ relationships	 ﾠ is	 ﾠ
comparable	 ﾠto	 ﾠthat	 ﾠof	 ﾠfamily	 ﾠhistory.	 ﾠFurthermore,	 ﾠwe	 ﾠcan	 ﾠcompare	 ﾠcomorbidity	 ﾠstatistics	 ﾠwith	 ﾠtypical	 ﾠ
relative	 ﾠ risk	 ﾠ values	 ﾠ found	 ﾠ in	 ﾠ genetic	 ﾠ susceptibility	 ﾠ studies.	 ﾠ For	 ﾠ example,	 ﾠ the	 ﾠ relative	 ﾠ risk	 ﾠ of	 ﾠ type	 ﾠ 2	 ﾠ
diabetes	 ﾠfor	 ﾠcarriers	 ﾠof	 ﾠthe	 ﾠat-ﾭ‐risk	 ﾠallele	 ﾠTCF7L2	 ﾠranges	 ﾠbetween	 ﾠRR∼1.45	 ﾠand	 ﾠ2.41	 ﾠ[27],	 ﾠwhereas	 ﾠthe	 ﾠ
rs2476601	 ﾠSNP	 ﾠin	 ﾠthe	 ﾠPTPN22	 ﾠgene	 ﾠconfers	 ﾠa	 ﾠgenetic	 ﾠrelative	 ﾠrisk	 ﾠfor	 ﾠrheumatoid	 ﾠarthritis	 ﾠof	 ﾠRR∼1.8	 ﾠ
[28,29].	 ﾠIn	 ﾠcontrast,	 ﾠthe	 ﾠRR	 ﾠfor	 ﾠa	 ﾠtype	 ﾠ2	 ﾠdiabetes	 ﾠof	 ﾠa	 ﾠpatient	 ﾠdiagnosed	 ﾠwith	 ﾠIschemic	 ﾠHeart	 ﾠDisease	 ﾠis	 ﾠ
RR∼1.61,	 ﾠwhereas	 ﾠa	 ﾠrheumatoid	 ﾠarthritis	 ﾠpatient	 ﾠis	 ﾠat	 ﾠRR∼3.64	 ﾠfor	 ﾠthe	 ﾠdisease	 ﾠif	 ﾠhe	 ﾠor	 ﾠshe	 ﾠis	 ﾠdiagnosed	 ﾠ9	 ﾠ
	 ﾠ
with	 ﾠosteoporosis	 ﾠ[30].	 ﾠThe	 ﾠstatistical	 ﾠstrength	 ﾠof	 ﾠthe	 ﾠobserved	 ﾠcomorbidities	 ﾠis	 ﾠtherefore	 ﾠcomparable	 ﾠto	 ﾠ
that	 ﾠfound	 ﾠin	 ﾠsiblings	 ﾠand	 ﾠgenetic	 ﾠsusceptibility	 ﾠstudies,	 ﾠa	 ﾠfavorable	 ﾠcomparison	 ﾠthat	 ﾠprovides	 ﾠfurther	 ﾠ
motivation	 ﾠto	 ﾠuse	 ﾠcomorbidity	 ﾠdata	 ﾠto	 ﾠexplore	 ﾠdisease	 ﾠrisk.	 ﾠ
RESULTS	 ﾠ
	 ﾠThe	 ﾠPhenotypic	 ﾠDisease	 ﾠNetwork	 ﾠ
We	 ﾠcan	 ﾠsummarize	 ﾠthe	 ﾠset	 ﾠof	 ﾠall	 ﾠcomorbidity	 ﾠassociations	 ﾠbetween	 ﾠall	 ﾠdiseases	 ﾠexpressed	 ﾠin	 ﾠthe	 ﾠ
study	 ﾠpopulation	 ﾠby	 ﾠconstructing	 ﾠa	 ﾠPhenotypic	 ﾠDisease	 ﾠNetwork	 ﾠ(PDN).	 ﾠIn	 ﾠthe	 ﾠPDN,	 ﾠnodes	 ﾠare	 ﾠdisease	 ﾠ
phenotypes	 ﾠ identified	 ﾠ by	 ﾠ unique	 ﾠ ICD9	 ﾠ codes,	 ﾠ and	 ﾠ links	 ﾠ connect	 ﾠ phenotypes	 ﾠ that	 ﾠ show	 ﾠ significant	 ﾠ
comorbidity	 ﾠaccording	 ﾠto	 ﾠthe	 ﾠmeasures	 ﾠintroduced	 ﾠabove.	 ﾠ	 ﾠ
In	 ﾠprinciple,	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠdisease-ﾭ‐disease	 ﾠassociations	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠis	 ﾠproportional	 ﾠto	 ﾠthe	 ﾠsquare	 ﾠ
of	 ﾠ the	 ﾠ number	 ﾠ of	 ﾠ phenotypes,	 ﾠ yet	 ﾠ many	 ﾠ of	 ﾠ these	 ﾠ associations	 ﾠ are	 ﾠ either	 ﾠ not	 ﾠ strong	 ﾠ or	 ﾠ are	 ﾠ not	 ﾠ
statistically	 ﾠ significant	 ﾠ (see	 ﾠ SM).	 ﾠ Hence,	 ﾠ we	 ﾠ explore	 ﾠ the	 ﾠ structure	 ﾠ of	 ﾠ the	 ﾠ PDN	 ﾠ by	 ﾠ focusing	 ﾠo n 	 ﾠt h e 	 ﾠ
strongest	 ﾠand	 ﾠmost	 ﾠsignificant	 ﾠof	 ﾠthese	 ﾠassociations.	 ﾠTo	 ﾠachieve	 ﾠthis,	 ﾠwe	 ﾠoffer	 ﾠtwo	 ﾠvisualizations	 ﾠof	 ﾠthe	 ﾠ
PDN	 ﾠ(see	 ﾠSM),	 ﾠthe	 ﾠfirst	 ﾠconstructed	 ﾠusing	 ﾠRR	 ﾠ(Fig	 ﾠ2	 ﾠA)	 ﾠand	 ﾠthe	 ﾠsecond	 ﾠusing	 ﾠφ	 ﾠ(Fig	 ﾠ2B	 ﾠand	 ﾠText	 ﾠS1).	 ﾠ
While	 ﾠthere	 ﾠare	 ﾠmany	 ﾠsimilarities	 ﾠbetween	 ﾠthe	 ﾠtwo	 ﾠnetworks,	 ﾠsuch	 ﾠas	 ﾠthe	 ﾠproximity	 ﾠbetween	 ﾠ
nephritis	 ﾠand	 ﾠhypertension	 ﾠor	 ﾠpsychiatric	 ﾠdisorders	 ﾠand	 ﾠpoisoning,	 ﾠthe	 ﾠoverall	 ﾠstructure	 ﾠof	 ﾠthe	 ﾠPDN	 ﾠand	 ﾠ
the	 ﾠspecific	 ﾠdisease	 ﾠgroups	 ﾠpresent	 ﾠin	 ﾠeach	 ﾠone	 ﾠof	 ﾠthem	 ﾠreflect	 ﾠthe	 ﾠindividual	 ﾠbiases	 ﾠof	 ﾠthe	 ﾠmetric	 ﾠused	 ﾠ
to	 ﾠconstruct	 ﾠthe	 ﾠlinks.	 ﾠThe	 ﾠnetwork	 ﾠconstructed	 ﾠusing	 ﾠRR	 ﾠ(Fig	 ﾠ2	 ﾠA)	 ﾠis	 ﾠpopulated	 ﾠby	 ﾠrelatively	 ﾠinfrequent	 ﾠ
illnesses	 ﾠand	 ﾠhas	 ﾠvisually	 ﾠdiscernable	 ﾠmodules	 ﾠthat	 ﾠfollow	 ﾠthe	 ﾠICD9	 ﾠclassification	 ﾠsomewhat	 ﾠclosely.	 ﾠIn	 ﾠ
contrast,	 ﾠthe	 ﾠnetwork	 ﾠconstructed	 ﾠusing	 ﾠφ	 ﾠ(Fig	 ﾠ2	 ﾠB)	 ﾠis	 ﾠpopulated	 ﾠby	 ﾠhighly	 ﾠprevalent	 ﾠdiseases	 ﾠwith	 ﾠmany	 ﾠ
connections	 ﾠacross	 ﾠdifferent	 ﾠICD9	 ﾠcategories.	 ﾠDespite	 ﾠthese	 ﾠdifferences	 ﾠbetween	 ﾠthe	 ﾠtwo	 ﾠnetworks,	 ﾠwe	 ﾠ10	 ﾠ
	 ﾠ
do	 ﾠ not	 ﾠ argue	 ﾠ in	 ﾠ favor	 ﾠ of	 ﾠ one	 ﾠ particular	 ﾠ representation;	 ﾠ they	 ﾠ both	 ﾠ capture	 ﾠ statistically	 ﾠ significant	 ﾠ
associations	 ﾠat	 ﾠdifferent	 ﾠprevalence	 ﾠscales.	 ﾠTogether,	 ﾠeach	 ﾠoffers	 ﾠa	 ﾠcomplementary	 ﾠrepresentation	 ﾠof	 ﾠ
the	 ﾠphenotypic	 ﾠdisease	 ﾠnetwork.	 ﾠ
Disease	 ﾠNetwork	 ﾠDynamics	 ﾠ
	 ﾠ
While	 ﾠa 	 ﾠn e t w o r k 	 ﾠr e p r e s e n t a t i o n 	 ﾠo f 	 ﾠd i s e a s e s 	 ﾠh a s 	 ﾠm a n y 	 ﾠp o t e n t i a l 	 ﾠa p p l i c a t i o n s , 	 ﾠh e r e 	 ﾠw e 	 ﾠ
concentrate	 ﾠon	 ﾠthree	 ﾠexamples	 ﾠillustrating	 ﾠthe	 ﾠuse	 ﾠof	 ﾠthe	 ﾠPDN	 ﾠto	 ﾠstudy	 ﾠthe	 ﾠillness	 ﾠprogression	 ﾠfrom	 ﾠa	 ﾠ
network	 ﾠdynamics	 ﾠperspective	 ﾠ[31].	 ﾠThe	 ﾠPDN	 ﾠcan	 ﾠbe	 ﾠseen	 ﾠas	 ﾠa	 ﾠ“map”	 ﾠof	 ﾠthe	 ﾠphenotypic	 ﾠspace.	 ﾠThis	 ﾠmap	 ﾠ
allows	 ﾠus	 ﾠto	 ﾠstudy	 ﾠillness	 ﾠprogression	 ﾠas	 ﾠa	 ﾠdynamic	 ﾠnetwork	 ﾠprocess	 ﾠin	 ﾠwhich	 ﾠpatients	 ﾠ“jump”	 ﾠfrom	 ﾠone	 ﾠ
disease	 ﾠto	 ﾠanother	 ﾠalong	 ﾠthe	 ﾠlinks	 ﾠof	 ﾠthe	 ﾠPDN	 ﾠ[31].	 ﾠOur	 ﾠability	 ﾠto	 ﾠfully	 ﾠdevelop	 ﾠsuch	 ﾠa	 ﾠview	 ﾠof	 ﾠdiseases	 ﾠis	 ﾠ
limited,	 ﾠhowever,	 ﾠby	 ﾠour	 ﾠdata.	 ﾠWhile	 ﾠwe	 ﾠcan	 ﾠorder	 ﾠdiseases	 ﾠaccording	 ﾠto	 ﾠthe	 ﾠdate	 ﾠthey	 ﾠwere	 ﾠdiagnosed,	 ﾠ
we	 ﾠcannot	 ﾠexclude	 ﾠthe	 ﾠpossibility	 ﾠthat	 ﾠthe	 ﾠobserved	 ﾠprogression	 ﾠis	 ﾠa	 ﾠresult	 ﾠof	 ﾠour	 ﾠlimited	 ﾠobservation	 ﾠ
window.	 ﾠFor	 ﾠexample,	 ﾠa	 ﾠpatient	 ﾠin	 ﾠour	 ﾠdata	 ﾠset	 ﾠcan	 ﾠbe	 ﾠdiagnosed	 ﾠwith	 ﾠtype	 ﾠII	 ﾠdiabetes	 ﾠon	 ﾠthe	 ﾠfirst	 ﾠvisit	 ﾠ
and	 ﾠhypertension	 ﾠon	 ﾠthe	 ﾠsecond	 ﾠvisit.	 ﾠYet,	 ﾠlacking	 ﾠinformation	 ﾠon	 ﾠprevious	 ﾠdisease	 ﾠhistory,	 ﾠwe	 ﾠcannot	 ﾠ
conclude	 ﾠ that	 ﾠ diabetes	 ﾠ precedes	 ﾠ hypertension,	 ﾠ as	 ﾠ hypertension	 ﾠ could	 ﾠ have	 ﾠ been	 ﾠ diagnosed	 ﾠ at	 ﾠ any	 ﾠ
earlier	 ﾠtime	 ﾠpoint	 ﾠnot	 ﾠrecorded	 ﾠin	 ﾠour	 ﾠdata.	 ﾠHence	 ﾠwe	 ﾠbegin	 ﾠour	 ﾠanalysis	 ﾠusing	 ﾠa	 ﾠconservative	 ﾠapproach	 ﾠ
in	 ﾠ which	 ﾠ we	 ﾠ study	 ﾠ possible	 ﾠ consequences	 ﾠ of	 ﾠ disease	 ﾠ progression	 ﾠ in	 ﾠ a	 ﾠ static	 ﾠ network	 ﾠ picture	 ﾠ and	 ﾠ
continue,	 ﾠby	 ﾠthe	 ﾠend	 ﾠof	 ﾠthe	 ﾠpaper,	 ﾠto	 ﾠstudy	 ﾠthe	 ﾠobserved	 ﾠdirectionality	 ﾠof	 ﾠdisease	 ﾠprogression,	 ﾠlimiting	 ﾠ
any	 ﾠconclusions	 ﾠdue	 ﾠto	 ﾠthe	 ﾠaforementioned	 ﾠbiases.	 ﾠ
	 ﾠ These	 ﾠlimitations	 ﾠrequire	 ﾠus	 ﾠto	 ﾠadopt	 ﾠa	 ﾠmore	 ﾠconservative	 ﾠapproach	 ﾠin	 ﾠour	 ﾠanalysis.	 ﾠHere	 ﾠwe	 ﾠ
explore	 ﾠdisease	 ﾠnetwork	 ﾠdynamics	 ﾠby	 ﾠasking	 ﾠthree	 ﾠquestions	 ﾠ(Fig	 ﾠ3	 ﾠA).	 ﾠQ1:	 ﾠDoes	 ﾠillness	 ﾠsignificantly	 ﾠ
progress	 ﾠalong	 ﾠthe	 ﾠlinks	 ﾠof	 ﾠthe	 ﾠPDN?	 ﾠQ2:	 ﾠIs	 ﾠillness	 ﾠprogression	 ﾠdifferent	 ﾠfor	 ﾠpatients	 ﾠof	 ﾠdifferent	 ﾠraces	 ﾠand	 ﾠ11	 ﾠ
	 ﾠ
genders?	 ﾠ Q3:	 ﾠ Does	 ﾠ the	 ﾠ connectivity	 ﾠ of	 ﾠ a	 ﾠ disease,	 ﾠ as	 ﾠ measured	 ﾠ in	 ﾠ the	 ﾠ PDN,	 ﾠ correlates	 ﾠ with	 ﾠ higher	 ﾠ
lethality?	 ﾠ	 ﾠ
To	 ﾠanswer	 ﾠthe	 ﾠfirst	 ﾠquestion	 ﾠ(Q1)	 ﾠwe	 ﾠuse	 ﾠa	 ﾠrecently	 ﾠintroduced	 ﾠmethod	 ﾠto	 ﾠdecide	 ﾠwhether	 ﾠa	 ﾠ
node	 ﾠ property	 ﾠ spreads	 ﾠ along	 ﾠ the	 ﾠ links	 ﾠ of	 ﾠ a	 ﾠ network	 ﾠ [31]	 ﾠ (see	 ﾠ Text	 ﾠ S1).	 ﾠ We	 ﾠ measure	 ﾠ the	 ﾠ average	 ﾠ
correlation	 ﾠbetween	 ﾠdiseases	 ﾠdiagnosed	 ﾠin	 ﾠthe	 ﾠfirst	 ﾠtwo	 ﾠvisits	 ﾠand	 ﾠthose	 ﾠdiagnosed	 ﾠin	 ﾠthe	 ﾠ3
rd	 ﾠand	 ﾠ4
th	 ﾠ
visits	 ﾠfor	 ﾠall	 ﾠpatients	 ﾠwith	 ﾠfour	 ﾠvisits	 ﾠ(N=946,580).	 ﾠWe	 ﾠcontrolled	 ﾠfor	 ﾠthe	 ﾠcorrelations	 ﾠinherent	 ﾠto	 ﾠthe	 ﾠ
dataset	 ﾠby	 ﾠrepeating	 ﾠthe	 ﾠprocedure	 ﾠusing	 ﾠa	 ﾠrandomized	 ﾠset	 ﾠof	 ﾠdiseases	 ﾠfor	 ﾠthe	 ﾠfirst	 ﾠtwo	 ﾠvisits	 ﾠextracted	 ﾠ
in	 ﾠsuch	 ﾠa	 ﾠway	 ﾠthat	 ﾠthe	 ﾠprevalence	 ﾠof	 ﾠeach	 ﾠdisease	 ﾠin	 ﾠthe	 ﾠrandomized	 ﾠsets	 ﾠmatches	 ﾠthe	 ﾠone	 ﾠobserved	 ﾠin	 ﾠ
the	 ﾠoriginal	 ﾠdata.	 ﾠWe	 ﾠfind	 ﾠthat	 ﾠdiseases	 ﾠdiagnosed	 ﾠin	 ﾠthe	 ﾠfirst	 ﾠtwo	 ﾠvisits	 ﾠare	 ﾠmore	 ﾠcorrelated	 ﾠwith	 ﾠthose	 ﾠ
diagnosed	 ﾠin	 ﾠthe	 ﾠlast	 ﾠtwo	 ﾠvisits	 ﾠthan	 ﾠwhat	 ﾠwe	 ﾠobserve	 ﾠon	 ﾠour	 ﾠcontrol	 ﾠcase	 ﾠ(Fig	 ﾠ3	 ﾠB	 ﾠ&	 ﾠC).	 ﾠIn	 ﾠa	 ﾠcase-ﾭ‐by-ﾭ‐case	 ﾠ
basis,	 ﾠwe	 ﾠcan	 ﾠcompare	 ﾠthe	 ﾠcorrelations	 ﾠbetween	 ﾠthe	 ﾠreal	 ﾠand	 ﾠrandomized	 ﾠmeasures	 ﾠby	 ﾠcalculating	 ﾠthe	 ﾠ
ratio	 ﾠ ,	 ﾠwhere	 ﾠ 	 ﾠis	 ﾠthe	 ﾠaverage	 ﾠcorrelation	 ﾠbetween	 ﾠthe	 ﾠdiagnoses	 ﾠreceived	 ﾠby	 ﾠa	 ﾠpatient	 ﾠin	 ﾠ
his	 ﾠ first	 ﾠ two	 ﾠ and	 ﾠ last	 ﾠ two	 ﾠ visits	 ﾠ and	 ﾠ 	 ﾠi s 	 ﾠt h e 	 ﾠa v e r a g e 	 ﾠc o r r e l a t i o n 	 ﾠf o u n d 	 ﾠin	 ﾠ the	 ﾠ control	 ﾠ case.	 ﾠ The	 ﾠ
distribution	 ﾠof	 ﾠH	 ﾠ(Fig	 ﾠ3	 ﾠD	 ﾠ&	 ﾠE)	 ﾠreveals	 ﾠthat	 ﾠinter-ﾭ‐visit	 ﾠcorrelations	 ﾠare	 ﾠlarger	 ﾠthan	 ﾠwould	 ﾠbe	 ﾠexpected	 ﾠby	 ﾠ
chance	 ﾠfor	 ﾠ95.6%	 ﾠof	 ﾠthe	 ﾠpatients	 ﾠon	 ﾠthe	 ﾠφ-ﾭ‐PDN	 ﾠand	 ﾠfor	 ﾠ81.5%	 ﾠof	 ﾠthe	 ﾠpatients	 ﾠin	 ﾠthe	 ﾠRR-ﾭ‐PDN	 ﾠ(by	 ﾠa	 ﾠfactor	 ﾠ
of	 ﾠ10	 ﾠon	 ﾠaverage	 ﾠfor	 ﾠthe	 ﾠφ-ﾭ‐PDN	 ﾠand	 ﾠof	 ﾠ1.5	 ﾠfor	 ﾠthe	 ﾠRR-ﾭ‐PDN).	 ﾠTherefore,	 ﾠit	 ﾠis	 ﾠa	 ﾠvalid	 ﾠapproximation	 ﾠto	 ﾠthink	 ﾠ
of	 ﾠthe	 ﾠdevelopment	 ﾠof	 ﾠpatients’	 ﾠillnesses	 ﾠas	 ﾠa	 ﾠspreading	 ﾠprocess	 ﾠover	 ﾠa	 ﾠPDN.	 ﾠWe	 ﾠnote	 ﾠthat	 ﾠwhile	 ﾠthe	 ﾠ
effect	 ﾠdiscussed	 ﾠabove	 ﾠis	 ﾠpresent	 ﾠfor	 ﾠboth	 ﾠthe	 ﾠφ	 ﾠand	 ﾠRR-ﾭ‐based	 ﾠnetworks,	 ﾠit	 ﾠis	 ﾠmore	 ﾠpronounced	 ﾠin	 ﾠthe	 ﾠφ-ﾭ‐
PDN,	 ﾠsuggesting	 ﾠa	 ﾠsuperior	 ﾠpotential	 ﾠpredictive	 ﾠpower	 ﾠfor	 ﾠthe	 ﾠφ-ﾭ‐representation.	 ﾠWe	 ﾠfind	 ﾠthat	 ﾠthis	 ﾠresult	 ﾠ
is	 ﾠnot	 ﾠaffected	 ﾠby	 ﾠincluding	 ﾠthe	 ﾠindividuals	 ﾠwith	 ﾠfour	 ﾠvisits	 ﾠor	 ﾠnot	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠ(see	 ﾠText	 ﾠS1).	 ﾠThis	 ﾠis	 ﾠbecause	 ﾠ
of	 ﾠthe	 ﾠlarge	 ﾠnumber	 ﾠof	 ﾠobservations	 ﾠand	 ﾠthe	 ﾠregularity	 ﾠof	 ﾠthe	 ﾠobserved	 ﾠdisease	 ﾠcorrelations.	 ﾠ12	 ﾠ
	 ﾠ
While	 ﾠ our	 ﾠ data	 ﾠ does	 ﾠ not	 ﾠ allow	 ﾠ us	 ﾠ to	 ﾠ be	 ﾠ conclusive	 ﾠ about	 ﾠ the	 ﾠ directionality	 ﾠ of	 ﾠ disease	 ﾠ
progression,	 ﾠdifferences	 ﾠin	 ﾠthe	 ﾠstrength	 ﾠof	 ﾠcomorbidity	 ﾠrelationships	 ﾠcan	 ﾠstill	 ﾠindicate	 ﾠdifferences	 ﾠin	 ﾠthe	 ﾠ
dynamics	 ﾠof	 ﾠillness	 ﾠprogression.	 ﾠThe	 ﾠreason	 ﾠis	 ﾠthat	 ﾠpatients	 ﾠaffected	 ﾠby	 ﾠa	 ﾠpair	 ﾠof	 ﾠdiseases	 ﾠhad	 ﾠtraversed	 ﾠ
the	 ﾠlink	 ﾠbetween	 ﾠthem	 ﾠat	 ﾠsome	 ﾠpoint	 ﾠin	 ﾠtime	 ﾠand	 ﾠin	 ﾠone	 ﾠof	 ﾠthe	 ﾠtwo	 ﾠpossible	 ﾠdirections.	 ﾠHere,	 ﾠwe	 ﾠexplore	 ﾠ
Q2	 ﾠby	 ﾠlooking	 ﾠat	 ﾠdifferences	 ﾠin	 ﾠthe	 ﾠstrength	 ﾠof	 ﾠthe	 ﾠobserved	 ﾠcomorbidities	 ﾠfor	 ﾠpatients	 ﾠfrom	 ﾠdifferent	 ﾠ
ethnic	 ﾠbackground	 ﾠand	 ﾠgenders.	 ﾠFor	 ﾠthis	 ﾠwe	 ﾠcalculate	 ﾠthe	 ﾠodds	 ﾠratio	 ﾠfor	 ﾠthe	 ﾠdifference	 ﾠin	 ﾠcomorbidity	 ﾠ
between	 ﾠdiseases	 ﾠi	 ﾠand	 ﾠj	 ﾠas	 ﾠexpressed	 ﾠin	 ﾠpopulations	 ﾠα	 ﾠand	 ﾠβ.	 ﾠMathematically,	 ﾠthe	 ﾠodds	 ﾠratio	 ﾠis	 ﾠdefined	 ﾠ
as	 ﾠ
	 ﾠ,	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ(3)	 ﾠ
where	 ﾠpij(α)=	 ﾠCij(α)/Nα	 ﾠis	 ﾠthe	 ﾠprobability	 ﾠthat	 ﾠdiseases	 ﾠi	 ﾠand	 ﾠj	 ﾠare	 ﾠobserved	 ﾠin	 ﾠa	 ﾠpatient	 ﾠof	 ﾠpopulation	 ﾠα.	 ﾠ
We	 ﾠ discuss	 ﾠ as	 ﾠ an	 ﾠ example	 ﾠ a	 ﾠ network	 ﾠ showing	 ﾠ differences	 ﾠ in	 ﾠ the	 ﾠ strength	 ﾠ of	 ﾠ comorbidities	 ﾠ
between	 ﾠwhite	 ﾠand	 ﾠblack	 ﾠmales.	 ﾠWe	 ﾠillustrate	 ﾠthis	 ﾠon	 ﾠthe	 ﾠsubset	 ﾠof	 ﾠFigure	 ﾠ2	 ﾠB	 ﾠin	 ﾠwhich	 ﾠall	 ﾠdiseases	 ﾠ
connected	 ﾠ to	 ﾠ Hypertension	 ﾠ or	 ﾠ Ischemic	 ﾠ Heart	 ﾠ Disease	 ﾠ are	 ﾠ shown.	 ﾠ In	 ﾠ Figure	 ﾠ 3	 ﾠ F,	 ﾠ blue	 ﾠ links	 ﾠ connect	 ﾠ
diseases	 ﾠthat	 ﾠare	 ﾠsignificantly	 ﾠmore	 ﾠcomorbid	 ﾠfor	 ﾠblack	 ﾠmales,	 ﾠwhereas	 ﾠred	 ﾠlinks	 ﾠconnect	 ﾠdiseases	 ﾠthat	 ﾠ
are	 ﾠ more	 ﾠ comorbid	 ﾠ for	 ﾠ white	 ﾠ males.	 ﾠ This	 ﾠ picture	 ﾠ suggest	 ﾠ that	 ﾠ ischemic	 ﾠ heart	 ﾠ disease,	 ﾠ infarctions,	 ﾠ
hypercholesterolemia,	 ﾠand	 ﾠpulmonary	 ﾠcomplications,	 ﾠamong	 ﾠother	 ﾠdiseases,	 ﾠtend	 ﾠto	 ﾠbe	 ﾠmore	 ﾠcomorbid	 ﾠ
in	 ﾠwhite	 ﾠmales	 ﾠthan	 ﾠin	 ﾠblack	 ﾠmales;	 ﾠwhereas	 ﾠhypertension,	 ﾠdiabetes,	 ﾠand	 ﾠrenal	 ﾠand	 ﾠother	 ﾠdisorders	 ﾠtend	 ﾠ
to	 ﾠ be	 ﾠ more	 ﾠ comorbid	 ﾠ in	 ﾠ black	 ﾠ males	 ﾠ than	 ﾠ in	 ﾠ white	 ﾠ males.	 ﾠ The	 ﾠ structure	 ﾠ presented	 ﾠ in	 ﾠ Figure	 ﾠ 3	 ﾠ F	 ﾠ
summarizes	 ﾠwell	 ﾠknown	 ﾠdisease	 ﾠassociations,	 ﾠvalidating	 ﾠthe	 ﾠability	 ﾠof	 ﾠthe	 ﾠPDN	 ﾠto	 ﾠexplore	 ﾠgender	 ﾠand	 ﾠ
race	 ﾠvariations	 ﾠon	 ﾠcomorbidity,	 ﾠwhich	 ﾠcould	 ﾠhelp	 ﾠdiscern	 ﾠdisease	 ﾠetiology.	 ﾠFigure	 ﾠ5S	 ﾠshows	 ﾠa	 ﾠsimilar	 ﾠ
example	 ﾠfor	 ﾠmales	 ﾠand	 ﾠfemales.	 ﾠComparative	 ﾠstudies	 ﾠlike	 ﾠthis	 ﾠone	 ﾠcan	 ﾠbe	 ﾠperformed	 ﾠfor	 ﾠany	 ﾠdisease	 ﾠ
using	 ﾠthe	 ﾠproject’s	 ﾠwebsite	 ﾠ(http://hudine.neu.edu).	 ﾠ13	 ﾠ
	 ﾠ
Finally,	 ﾠwe	 ﾠexplore	 ﾠour	 ﾠthird	 ﾠquestion	 ﾠ(Q3)	 ﾠby	 ﾠshowing	 ﾠthat	 ﾠthe	 ﾠlethality	 ﾠof	 ﾠa	 ﾠdisease	 ﾠis	 ﾠassociated	 ﾠ
with	 ﾠits	 ﾠconnectivity	 ﾠin	 ﾠthe	 ﾠPDN.	 ﾠWe	 ﾠcan	 ﾠquantify	 ﾠthe	 ﾠconnectivity	 ﾠof	 ﾠa	 ﾠparticular	 ﾠdisease	 ﾠby	 ﾠadding	 ﾠthe	 ﾠ
correlations	 ﾠ between	 ﾠ a	 ﾠ disease	 ﾠ and	 ﾠ all	 ﾠ other	 ﾠ diseases	 ﾠ to	 ﾠ which	 ﾠ it	 ﾠ is	 ﾠ connected	 ﾠ [32,33].	 ﾠ We	 ﾠ use	 ﾠ
	 ﾠand	 ﾠ 	 ﾠrespectively	 ﾠfor	 ﾠthe	 ﾠφ-ﾭ‐	 ﾠand	 ﾠRR-ﾭ‐networks.	 ﾠBoth	 ﾠ 	 ﾠand	 ﾠ 	 ﾠtell	 ﾠus	 ﾠhow	 ﾠ
embedded	 ﾠ disease	 ﾠ i	 ﾠi s 	 ﾠi n 	 ﾠt h e 	 ﾠP D N ; 	 ﾠh i g h 	 ﾠv a l u e s 	 ﾠo f 	 ﾠ 	 ﾠa n d 	 ﾠ 	 ﾠi n d i c a t e 	 ﾠt h a t 	 ﾠd i s e a s e 	 ﾠi	 ﾠ is	 ﾠs t r o n g l y 	 ﾠ
connected	 ﾠto	 ﾠmany	 ﾠother	 ﾠdiseases	 ﾠin	 ﾠthe	 ﾠPDN.	 ﾠTo	 ﾠmeasure	 ﾠthe	 ﾠlethality	 ﾠof	 ﾠa	 ﾠdisease,	 ﾠwe	 ﾠcalculated	 ﾠthe	 ﾠ
percentage	 ﾠof	 ﾠpeople	 ﾠdeceased	 ﾠwithin	 ﾠthe	 ﾠ8	 ﾠyears	 ﾠfollowing	 ﾠthe	 ﾠfirst	 ﾠdiagnosis	 ﾠrecorded	 ﾠin	 ﾠour	 ﾠdatabase.	 ﾠ
We	 ﾠfind	 ﾠthat	 ﾠdisease	 ﾠconnectivity	 ﾠand	 ﾠlethality	 ﾠare	 ﾠcorrelated	 ﾠfor	 ﾠthe	 ﾠφ-ﾭ‐PDN	 ﾠand	 ﾠthe	 ﾠRR-ﾭ‐PDN	 ﾠ(Fig	 ﾠ4	 ﾠA	 ﾠ&	 ﾠ
B).	 ﾠA	 ﾠsimpler	 ﾠand	 ﾠcontrasting	 ﾠhypothesis	 ﾠis	 ﾠto	 ﾠtest	 ﾠwhether	 ﾠthe	 ﾠlethality	 ﾠof	 ﾠa	 ﾠdisease	 ﾠcorrelates	 ﾠwith	 ﾠits	 ﾠ
prevalence	 ﾠ(Fig	 ﾠ4	 ﾠC);	 ﾠwe	 ﾠfind	 ﾠthat	 ﾠprevalence	 ﾠshows	 ﾠonly	 ﾠa	 ﾠweak	 ﾠcorrelation	 ﾠwith	 ﾠlethality	 ﾠand	 ﾠcannot	 ﾠ
explain	 ﾠthe	 ﾠeffect	 ﾠseen	 ﾠin	 ﾠFig	 ﾠ4	 ﾠA	 ﾠ&	 ﾠB.	 ﾠWe	 ﾠalso	 ﾠfind	 ﾠthat	 ﾠthe	 ﾠstrength	 ﾠof	 ﾠthe	 ﾠrelationship	 ﾠbetween	 ﾠdisease	 ﾠ
connectivity	 ﾠand	 ﾠlethality	 ﾠis	 ﾠgreater	 ﾠfor	 ﾠsome	 ﾠgroups	 ﾠof	 ﾠdiseases	 ﾠthan	 ﾠothers	 ﾠ(Table	 ﾠS3).	 ﾠ	 ﾠFor	 ﾠexample,	 ﾠ
this	 ﾠrelationship	 ﾠis	 ﾠstrong	 ﾠfor	 ﾠneoplasms	 ﾠ(Fig	 ﾠ4	 ﾠD	 ﾠ&	 ﾠE)	 ﾠwhereas	 ﾠfor	 ﾠmental	 ﾠdisorders	 ﾠthe	 ﾠcorrelation	 ﾠis	 ﾠ
week	 ﾠ(Fig	 ﾠ4	 ﾠF)	 ﾠor	 ﾠeven	 ﾠnegative	 ﾠ(Fig	 ﾠ4	 ﾠG).	 ﾠ	 ﾠ
A	 ﾠpossible	 ﾠexplanation	 ﾠfor	 ﾠthe	 ﾠobserved	 ﾠcorrelation	 ﾠbetween	 ﾠconnectivity	 ﾠand	 ﾠlethality	 ﾠis	 ﾠthat	 ﾠ
sicker	 ﾠpatients	 ﾠaccrue	 ﾠmore	 ﾠdiagnoses	 ﾠand	 ﾠhence	 ﾠthe	 ﾠobserved	 ﾠcorrelation	 ﾠis	 ﾠjust	 ﾠa	 ﾠrestatement	 ﾠof	 ﾠthis	 ﾠ
trivial	 ﾠfact.	 ﾠWe	 ﾠcan	 ﾠrule	 ﾠthis	 ﾠout	 ﾠby	 ﾠlooking	 ﾠat	 ﾠthe	 ﾠcorrelation	 ﾠbetween	 ﾠthe	 ﾠaverage	 ﾠconnectivity	 ﾠof	 ﾠ
diseases	 ﾠdiagnosed	 ﾠto	 ﾠpatients	 ﾠwith	 ﾠa	 ﾠgiven	 ﾠnumber	 ﾠof	 ﾠhospital	 ﾠvisits,	 ﾠdiagnoses,	 ﾠand	 ﾠnumber	 ﾠof	 ﾠyears	 ﾠ
they	 ﾠremained	 ﾠalive	 ﾠafter	 ﾠthe	 ﾠlast	 ﾠdiagnosis	 ﾠwas	 ﾠobserved.	 ﾠWe	 ﾠperformed	 ﾠthis	 ﾠanalysis	 ﾠby	 ﾠlooking	 ﾠat	 ﾠdata	 ﾠ
on	 ﾠthe	 ﾠ7,878,255	 ﾠpatients	 ﾠfor	 ﾠwhich	 ﾠwe	 ﾠknow	 ﾠthe	 ﾠexact	 ﾠyear	 ﾠof	 ﾠdeath;	 ﾠthe	 ﾠremaining	 ﾠpatients	 ﾠwere	 ﾠ
reported	 ﾠas	 ﾠeither	 ﾠalive	 ﾠor	 ﾠunknown	 ﾠin	 ﾠour	 ﾠdata	 ﾠset.	 ﾠFigures	 ﾠ5	 ﾠA	 ﾠand	 ﾠ5	 ﾠB	 ﾠshow	 ﾠthe	 ﾠhistogram	 ﾠfor	 ﾠthe	 ﾠ
number	 ﾠof	 ﾠvisits	 ﾠand	 ﾠdiagnoses	 ﾠassigned	 ﾠto	 ﾠthis	 ﾠset	 ﾠof	 ﾠ7,878,255	 ﾠpatients.	 ﾠFigures	 ﾠ5	 ﾠC	 ﾠand	 ﾠ5	 ﾠD	 ﾠshow	 ﾠthat	 ﾠ
there	 ﾠis	 ﾠa	 ﾠsignificant	 ﾠnegative	 ﾠcorrelation	 ﾠbetween	 ﾠthe	 ﾠaverage	 ﾠconnectivity	 ﾠof	 ﾠdiseases	 ﾠobserved	 ﾠin	 ﾠ14	 ﾠ
	 ﾠ
patients	 ﾠwith	 ﾠthe	 ﾠsame	 ﾠnumber	 ﾠof	 ﾠvisits	 ﾠor	 ﾠdiagnoses	 ﾠor	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠyears	 ﾠthey	 ﾠsurvived	 ﾠafter	 ﾠthe	 ﾠlast	 ﾠ
diagnosis	 ﾠwas	 ﾠobserved.	 ﾠHence	 ﾠthe	 ﾠobserved	 ﾠcorrelation	 ﾠbetween	 ﾠconnectivity	 ﾠand	 ﾠlethality	 ﾠdoes	 ﾠnot	 ﾠ
come	 ﾠfrom	 ﾠa	 ﾠsimple	 ﾠaccumulation	 ﾠof	 ﾠdiagnoses	 ﾠby	 ﾠsicker	 ﾠpatients.	 ﾠOur	 ﾠresults	 ﾠindicate	 ﾠthat	 ﾠthe	 ﾠseverity	 ﾠ
of	 ﾠa	 ﾠdisease	 ﾠcan	 ﾠbe	 ﾠapproximated	 ﾠby	 ﾠits	 ﾠconnectivity	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠfor	 ﾠpatients	 ﾠwith	 ﾠthe	 ﾠsame	 ﾠnumber	 ﾠof	 ﾠ
diagnoses,	 ﾠhence	 ﾠthe	 ﾠstructure	 ﾠof	 ﾠthe	 ﾠPDN	 ﾠmatters	 ﾠas	 ﾠthe	 ﾠlocation	 ﾠof	 ﾠa	 ﾠpatient	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠis	 ﾠa	 ﾠpredictor	 ﾠ
of	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠyears	 ﾠhe	 ﾠis	 ﾠexpected	 ﾠto	 ﾠremain	 ﾠalive.	 ﾠ	 ﾠWe	 ﾠalso	 ﾠnotice	 ﾠthat	 ﾠin	 ﾠthis	 ﾠexample	 ﾠthe	 ﾠPDN	 ﾠ
created	 ﾠusing	 ﾠφ	 ﾠcorrelates	 ﾠmore	 ﾠstrongly	 ﾠwith	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠyears	 ﾠa	 ﾠperson	 ﾠsurvived	 ﾠthan	 ﾠthe	 ﾠRR-ﾭ‐PDN.	 ﾠ
In	 ﾠText	 ﾠS1,	 ﾠwe	 ﾠshow	 ﾠthat	 ﾠthe	 ﾠobserved	 ﾠcorrelation	 ﾠbetween	 ﾠthe	 ﾠconnectivity	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠof	 ﾠdiseases	 ﾠ
affecting	 ﾠa	 ﾠpatient	 ﾠand	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠyears	 ﾠsurvived	 ﾠare	 ﾠrobust	 ﾠto	 ﾠsimultaneous	 ﾠcontrol	 ﾠfor	 ﾠage,	 ﾠgender,	 ﾠ
number	 ﾠof	 ﾠdiagnoses,	 ﾠand	 ﾠnumber	 ﾠof	 ﾠvisits.	 ﾠ
Finally,	 ﾠwe	 ﾠbriefly	 ﾠanalyze	 ﾠthe	 ﾠdirectionality	 ﾠof	 ﾠdisease	 ﾠprogression,	 ﾠas	 ﾠobserved	 ﾠin	 ﾠour	 ﾠdata,	 ﾠ
keeping	 ﾠin	 ﾠmind	 ﾠthat	 ﾠthe	 ﾠlimited	 ﾠobservation	 ﾠperiod	 ﾠof	 ﾠour	 ﾠstudy	 ﾠlimits	 ﾠour	 ﾠability	 ﾠto	 ﾠbe	 ﾠconclusive	 ﾠabout	 ﾠ
disease	 ﾠdirectionality	 ﾠbecause	 ﾠof	 ﾠthe	 ﾠaforementioned	 ﾠreasons.	 ﾠHence,	 ﾠwe	 ﾠinterpret	 ﾠthe	 ﾠfollowing	 ﾠresults	 ﾠ
as	 ﾠsuggestive	 ﾠevidence	 ﾠof	 ﾠdirectionality	 ﾠrather	 ﾠthan	 ﾠas	 ﾠa	 ﾠproof.	 ﾠTo	 ﾠreduce	 ﾠthe	 ﾠnoise	 ﾠlevels	 ﾠof	 ﾠour	 ﾠanalysis	 ﾠ
we	 ﾠconcentrate	 ﾠon	 ﾠlinks	 ﾠbetween	 ﾠdiseases	 ﾠaffecting	 ﾠat	 ﾠleast	 ﾠ1	 ﾠin	 ﾠ500	 ﾠpatients	 ﾠ(0.2%),	 ﾠwhich	 ﾠfrom	 ﾠthe	 ﾠsize	 ﾠ
of	 ﾠour	 ﾠdata	 ﾠset,	 ﾠare	 ﾠexpected	 ﾠto	 ﾠco-ﾭ‐occur	 ﾠin	 ﾠat	 ﾠleast	 ﾠ50	 ﾠpatients.	 ﾠAt	 ﾠthe	 ﾠ5	 ﾠdigit	 ﾠlevel	 ﾠour	 ﾠcomorbidity	 ﾠdata	 ﾠ
contains	 ﾠ133,858	 ﾠlinks	 ﾠconnecting	 ﾠthe	 ﾠ518	 ﾠdiseases	 ﾠaffecting	 ﾠat	 ﾠleast	 ﾠ1	 ﾠout	 ﾠof	 ﾠ500	 ﾠpatients.	 ﾠ	 ﾠ
Consider	 ﾠthe	 ﾠlink	 ﾠconnecting	 ﾠdiseases	 ﾠi	 ﾠand	 ﾠj.	 ﾠ	 ﾠTo	 ﾠassign	 ﾠa	 ﾠdirection	 ﾠto	 ﾠthis	 ﾠlink	 ﾠwe	 ﾠbegin	 ﾠcounting	 ﾠ
the	 ﾠnumber	 ﾠof	 ﾠtimes	 ﾠdisease	 ﾠi	 ﾠwas	 ﾠdiagnosed	 ﾠbefore	 ﾠdisease	 ﾠj	 ﾠand	 ﾠrepresent	 ﾠthis	 ﾠnumber	 ﾠas	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠLi-ﾭ‐>j.	 ﾠWhen	 ﾠ
computing	 ﾠLi-ﾭ‐>j	 ﾠwe	 ﾠdisregard	 ﾠthose	 ﾠcases	 ﾠin	 ﾠwhich	 ﾠboth	 ﾠdiseases	 ﾠwere	 ﾠdiagnosed	 ﾠfor	 ﾠthe	 ﾠfirst	 ﾠtime	 ﾠin	 ﾠthe	 ﾠ
same	 ﾠvisit,	 ﾠas	 ﾠour	 ﾠdata	 ﾠdoes	 ﾠnot	 ﾠallow	 ﾠus	 ﾠto	 ﾠstudy	 ﾠprecedence	 ﾠwithin	 ﾠthe	 ﾠsame	 ﾠhospitalization;	 ﾠhence	 ﾠLi-ﾭ‐>j	 ﾠ
+	 ﾠLj-ﾭ‐>i	 ﾠ≤	 ﾠCij.	 ﾠMost	 ﾠlinks	 ﾠconnect	 ﾠdiseases	 ﾠwith	 ﾠlarge	 ﾠdifferences	 ﾠin	 ﾠprevalence;	 ﾠhence	 ﾠwe	 ﾠnormalize	 ﾠLi-ﾭ‐>j	 ﾠby	 ﾠ
the	 ﾠprevalence	 ﾠof	 ﾠthe	 ﾠdisease	 ﾠi	 ﾠusing	 ﾠthe	 ﾠformula	 ﾠli-ﾭ‐>j=(Li-ﾭ‐>j+1)/Pi,	 ﾠwhere	 ﾠthe	 ﾠfactor	 ﾠof	 ﾠone	 ﾠis	 ﾠadded	 ﾠto	 ﾠ15	 ﾠ
	 ﾠ
include,	 ﾠ when	 ﾠ taking	 ﾠ ratios,	 ﾠ those	 ﾠ cases	 ﾠ in	 ﾠ which	 ﾠ Li-ﾭ‐>j	 ﾠi s 	 ﾠe q u a l 	 ﾠt o 	 ﾠz e r o . 	 ﾠI n 	 ﾠs u c h 	 ﾠc a s e s 	 ﾠli-ﾭ‐>j=1/Pi	 ﾠ. 	 ﾠWe 	 ﾠ
introduce	 ﾠthis	 ﾠnormalization	 ﾠbecause	 ﾠthe	 ﾠprobability	 ﾠthat	 ﾠa	 ﾠdisease	 ﾠis	 ﾠdiagnosed	 ﾠbefore	 ﾠanother	 ﾠdisease	 ﾠ
is	 ﾠproportional	 ﾠto	 ﾠits	 ﾠprevalence.	 ﾠFinally,	 ﾠwe	 ﾠcan	 ﾠassign	 ﾠa	 ﾠdirection	 ﾠto	 ﾠa	 ﾠlink	 ﾠby	 ﾠcreating	 ﾠa	 ﾠvariable	 ﾠthat,	 ﾠ
after	 ﾠcontrolling	 ﾠfor	 ﾠthe	 ﾠprevalence	 ﾠof	 ﾠa	 ﾠdisease,	 ﾠis	 ﾠpositive	 ﾠif	 ﾠa	 ﾠdisease	 ﾠtends	 ﾠto	 ﾠprecede	 ﾠanother	 ﾠdisease	 ﾠ
(outgoing	 ﾠlink)	 ﾠand	 ﾠnegative	 ﾠif	 ﾠa	 ﾠdisease	 ﾠtends	 ﾠto	 ﾠcome	 ﾠafter	 ﾠthe	 ﾠdisease	 ﾠat	 ﾠthe	 ﾠother	 ﾠend	 ﾠof	 ﾠthat	 ﾠlink	 ﾠ
(incoming	 ﾠlink).	 ﾠWe	 ﾠdefine	 ﾠthe	 ﾠdirectionality	 ﾠλi-ﾭ‐>j	 ﾠof	 ﾠthe	 ﾠlink	 ﾠconnecting	 ﾠdisease	 ﾠi	 ﾠto	 ﾠdisease	 ﾠj	 ﾠas:	 ﾠ	 ﾠ
	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ(4)	 ﾠ
A	 ﾠvalue	 ﾠof	 ﾠλi-ﾭ‐>j	 ﾠ=1	 ﾠindicates	 ﾠthat,	 ﾠafter	 ﾠcontrolling	 ﾠfor	 ﾠprevalence,	 ﾠthe	 ﾠprobability	 ﾠa	 ﾠpatient	 ﾠis	 ﾠ
diagnosed	 ﾠwith	 ﾠdisease	 ﾠi	 ﾠbefore	 ﾠit	 ﾠis	 ﾠdiagnosed	 ﾠwith	 ﾠdisease	 ﾠj	 ﾠis	 ﾠ10	 ﾠtimes	 ﾠhigher	 ﾠthan	 ﾠthe	 ﾠprobability	 ﾠa	 ﾠ
patient	 ﾠis	 ﾠdiagnosed	 ﾠwith	 ﾠdisease	 ﾠj	 ﾠbefore	 ﾠbeing	 ﾠdiagnosed	 ﾠwith	 ﾠdisease	 ﾠi.	 ﾠWhereas	 ﾠa	 ﾠvalue	 ﾠof	 ﾠλi-ﾭ‐>j=2	 ﾠ
indicates	 ﾠthat	 ﾠthe	 ﾠratio	 ﾠbetween	 ﾠthis	 ﾠprobabilities	 ﾠis	 ﾠequal	 ﾠto	 ﾠ100.	 ﾠFig	 ﾠ6	 ﾠA	 ﾠshows	 ﾠthe	 ﾠdistribution	 ﾠof	 ﾠλi-ﾭ‐>j	 ﾠ
calculated	 ﾠfor	 ﾠthe	 ﾠ133,858	 ﾠlinks	 ﾠconnecting	 ﾠdiseases	 ﾠaffecting	 ﾠat	 ﾠleast	 ﾠ1	 ﾠout	 ﾠof	 ﾠ500	 ﾠpatients.	 ﾠWe	 ﾠfind	 ﾠthat	 ﾠ
this	 ﾠdistribution	 ﾠhas	 ﾠa	 ﾠwell	 ﾠdefined	 ﾠpeak	 ﾠclose	 ﾠto	 ﾠλi-ﾭ‐>j=0,	 ﾠindicating	 ﾠthat	 ﾠthe	 ﾠmost	 ﾠcommon	 ﾠtype	 ﾠof	 ﾠlink	 ﾠis	 ﾠ
that	 ﾠwithout	 ﾠa	 ﾠpreferred	 ﾠdirection.	 ﾠDespite	 ﾠthis,	 ﾠthere	 ﾠare	 ﾠa	 ﾠsubstantial	 ﾠnumber	 ﾠof	 ﾠlinks	 ﾠthat	 ﾠdo	 ﾠappear	 ﾠ
to	 ﾠshow	 ﾠa	 ﾠpreferred	 ﾠdirection.	 ﾠWe	 ﾠfind	 ﾠthat,	 ﾠout	 ﾠof	 ﾠthe	 ﾠ133,858	 ﾠlinks	 ﾠconsidered,	 ﾠ15,625	 ﾠ(11.7%)	 ﾠof	 ﾠthem	 ﾠ
lie	 ﾠoutside	 ﾠthe	 ﾠλi-ﾭ‐>j	 ﾠ]-ﾭ‐1,1[	 ﾠwhereas	 ﾠonly	 ﾠ229	 ﾠ(0.2%)	 ﾠlie	 ﾠoutside	 ﾠthe	 ﾠλi-ﾭ‐>j	 ﾠ]-ﾭ‐2,2[	 ﾠ	 ﾠinterval.	 ﾠ	 ﾠ
The	 ﾠdirectionality	 ﾠanalysis	 ﾠallows	 ﾠus	 ﾠto	 ﾠextend	 ﾠour	 ﾠstudy	 ﾠof	 ﾠdisease	 ﾠconnectivity	 ﾠand	 ﾠlethality	 ﾠto	 ﾠ
include	 ﾠthe	 ﾠdirectionality	 ﾠof	 ﾠthe	 ﾠlinks	 ﾠconnecting	 ﾠa	 ﾠdisease	 ﾠto	 ﾠother	 ﾠdiseases	 ﾠin	 ﾠthe	 ﾠPDN.	 ﾠ	 ﾠBy	 ﾠassigning	 ﾠa	 ﾠ
direction	 ﾠto	 ﾠthe	 ﾠlinks	 ﾠconnecting	 ﾠa	 ﾠdisease	 ﾠwith	 ﾠother	 ﾠdiseases	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠwe	 ﾠcan	 ﾠclassify	 ﾠdiseases	 ﾠinto	 ﾠ
source	 ﾠand	 ﾠsink	 ﾠdiseases;	 ﾠsource	 ﾠdiseases	 ﾠbeing	 ﾠthose	 ﾠwhose	 ﾠlinks	 ﾠare	 ﾠmore	 ﾠlikely	 ﾠto	 ﾠpoint	 ﾠaway	 ﾠfrom	 ﾠ
them	 ﾠand	 ﾠsink	 ﾠdiseases	 ﾠbeing	 ﾠthose	 ﾠwhose	 ﾠlinks	 ﾠare	 ﾠmore	 ﾠlikely	 ﾠto	 ﾠpoint	 ﾠtowards	 ﾠthem.	 ﾠTo	 ﾠcapture	 ﾠthis	 ﾠ16	 ﾠ
	 ﾠ
effect	 ﾠwe	 ﾠdefine	 ﾠthe	 ﾠprecedence	 ﾠof	 ﾠdisease	 ﾠi	 ﾠas	 ﾠthe	 ﾠsum	 ﾠof	 ﾠthe	 ﾠdirectionality	 ﾠof	 ﾠthe	 ﾠlinks	 ﾠconnecting	 ﾠa	 ﾠ
disease	 ﾠto	 ﾠall	 ﾠof	 ﾠits	 ﾠneighboring	 ﾠdiseases	 ﾠin	 ﾠthe	 ﾠPDN:	 ﾠ
	 ﾠ 	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ	 ﾠ(5)	 ﾠ
Λi	 ﾠis	 ﾠpositive	 ﾠfor	 ﾠdiseases	 ﾠthat	 ﾠtend	 ﾠto	 ﾠcome	 ﾠbefore	 ﾠother	 ﾠdiseases	 ﾠand	 ﾠis	 ﾠnegative	 ﾠfor	 ﾠdiseases	 ﾠ
that	 ﾠtend	 ﾠto	 ﾠcome	 ﾠafter	 ﾠother	 ﾠdiseases.	 ﾠWe	 ﾠfind	 ﾠthat	 ﾠΛi	 ﾠis	 ﾠnot	 ﾠindependent	 ﾠof	 ﾠdisease	 ﾠprevalence,	 ﾠas	 ﾠit	 ﾠ
exhibits	 ﾠa	 ﾠslow,	 ﾠlogarithmic,	 ﾠdependence	 ﾠon	 ﾠit	 ﾠ(Figure	 ﾠ6	 ﾠB).	 ﾠWe	 ﾠcan	 ﾠremove	 ﾠthe	 ﾠdependence	 ﾠof	 ﾠΛi	 ﾠin	 ﾠthe	 ﾠ
prevalence	 ﾠof	 ﾠa	 ﾠdisease	 ﾠby	 ﾠsubtracting	 ﾠthe	 ﾠtrend	 ﾠdirectly	 ﾠfrom	 ﾠit.	 ﾠThis	 ﾠallows	 ﾠus	 ﾠto	 ﾠobtain	 ﾠa	 ﾠdetrended	 ﾠ
measure	 ﾠof	 ﾠdisease	 ﾠprecedence	 ﾠ(Λi*, Figure	 ﾠ6	 ﾠB	 ﾠinset)	 ﾠwhich	 ﾠis	 ﾠindependent	 ﾠof	 ﾠprevalence	 ﾠand	 ﾠcan	 ﾠbe	 ﾠ
used	 ﾠto	 ﾠexplore	 ﾠthe	 ﾠinformation	 ﾠon	 ﾠlethality	 ﾠcontained	 ﾠin	 ﾠthe	 ﾠstructure	 ﾠof	 ﾠthe	 ﾠPDN.	 ﾠ
Figure	 ﾠ6	 ﾠC	 ﾠshows	 ﾠthat	 ﾠΛi* is	 ﾠnegatively	 ﾠcorrelated	 ﾠwith	 ﾠthe	 ﾠconnectivity	 ﾠof	 ﾠa	 ﾠdisease,	 ﾠindicating	 ﾠ
that	 ﾠ highly	 ﾠ connected	 ﾠ diseases	 ﾠ in	 ﾠ the	 ﾠ PDN	 ﾠ tend	 ﾠ to	 ﾠ come	 ﾠ after	 ﾠ other	 ﾠ diseases,	 ﾠ rather	 ﾠ than	 ﾠ before,	 ﾠ
suggesting	 ﾠthat	 ﾠhighly	 ﾠconnected	 ﾠdiseases	 ﾠmore	 ﾠlikely	 ﾠrepresent	 ﾠadvanced	 ﾠstages	 ﾠof	 ﾠillness.	 ﾠFinally,	 ﾠwe	 ﾠ
study	 ﾠthe	 ﾠrelationship	 ﾠbetween	 ﾠdisease	 ﾠprecedence	 ﾠand	 ﾠlethality,	 ﾠfinding	 ﾠthat	 ﾠpatients	 ﾠdiagnosed	 ﾠwith	 ﾠ
sink	 ﾠdiseases	 ﾠtend	 ﾠto	 ﾠdie	 ﾠsooner	 ﾠthan	 ﾠthose	 ﾠdiagnosed	 ﾠwith	 ﾠsource	 ﾠdiseases,	 ﾠas	 ﾠmeasured	 ﾠfrom	 ﾠour	 ﾠ
directionality	 ﾠ analysis	 ﾠ in	 ﾠ the	 ﾠ PDN.	 ﾠ We	 ﾠ checked	 ﾠ whether	 ﾠ this	 ﾠ result	 ﾠ was	 ﾠ just	 ﾠ a	 ﾠ restatement	 ﾠ of	 ﾠ our	 ﾠ
previous	 ﾠfinding,	 ﾠindicating	 ﾠthat	 ﾠpatients	 ﾠdiagnosed	 ﾠwith	 ﾠhighly	 ﾠconnected	 ﾠdiseases	 ﾠtend	 ﾠto	 ﾠdie	 ﾠsooner	 ﾠ
than	 ﾠthose	 ﾠdiagnosed	 ﾠwith	 ﾠsparsely	 ﾠconnected	 ﾠdiseases,	 ﾠand	 ﾠfound	 ﾠthat	 ﾠboth	 ﾠeffects	 ﾠare	 ﾠsimultaneously	 ﾠ
significant	 ﾠ(see	 ﾠSM).	 ﾠFurthermore,	 ﾠour	 ﾠstatistical	 ﾠanalysis	 ﾠshows	 ﾠthat	 ﾠfor	 ﾠrelatively	 ﾠshort	 ﾠterms	 ﾠ(2	 ﾠyears)	 ﾠ
disease	 ﾠ precedence	 ﾠ is	 ﾠ a	 ﾠ better	 ﾠ predictor	 ﾠ of	 ﾠl e t h a l i t y 	 ﾠt h a n 	 ﾠd i s e a s e 	 ﾠc o n n e c t i v i t y , 	 ﾠw h e r e a s 	 ﾠd i s e a s e 	 ﾠ
connectivity	 ﾠappears	 ﾠto	 ﾠbe	 ﾠa	 ﾠbetter	 ﾠpredictor	 ﾠof	 ﾠlethality	 ﾠthan	 ﾠdisease	 ﾠprecedence	 ﾠfor	 ﾠlonger	 ﾠterms	 ﾠ(8	 ﾠ
years).	 ﾠHence	 ﾠboth,	 ﾠthe	 ﾠconnectivity	 ﾠand	 ﾠprecedence	 ﾠof	 ﾠa	 ﾠdisease,	 ﾠcarry	 ﾠimportant	 ﾠinformation	 ﾠon	 ﾠthe	 ﾠ




	 ﾠ While	 ﾠthere	 ﾠis	 ﾠa	 ﾠgreat	 ﾠdeal	 ﾠof	 ﾠexpectation	 ﾠthat	 ﾠdisease	 ﾠassociations	 ﾠare	 ﾠof	 ﾠenormous	 ﾠpotential	 ﾠ
value	 ﾠto	 ﾠthe	 ﾠresearch	 ﾠcommunity,	 ﾠthe	 ﾠlack	 ﾠof	 ﾠphenotypic	 ﾠdata	 ﾠavailable	 ﾠto	 ﾠcomplement	 ﾠgenotypic	 ﾠand	 ﾠ
proteomic	 ﾠdatasets	 ﾠhas	 ﾠlimited	 ﾠscientific	 ﾠprogress	 ﾠtowards	 ﾠelucidating	 ﾠthe	 ﾠorigins	 ﾠof	 ﾠhuman	 ﾠdisease.	 ﾠ
Here	 ﾠwe	 ﾠtake	 ﾠa	 ﾠstep	 ﾠtoward	 ﾠrectifying	 ﾠthis	 ﾠsituation	 ﾠby	 ﾠintroducing	 ﾠan	 ﾠextensive,	 ﾠpublicly	 ﾠavailable	 ﾠdata	 ﾠ
set	 ﾠquantifying	 ﾠcomorbidity	 ﾠassociations	 ﾠexpressed	 ﾠin	 ﾠa	 ﾠlarge	 ﾠpopulation.	 ﾠ
	 ﾠ An	 ﾠ important	 ﾠ issue	 ﾠ raised	 ﾠ by	 ﾠ calls	 ﾠ for	 ﾠ phenotypic	 ﾠ network	 ﾠ information	 ﾠ is	 ﾠ the	 ﾠ potential	 ﾠ
integration	 ﾠof	 ﾠphenotypic	 ﾠdata	 ﾠwith	 ﾠgenetic	 ﾠand	 ﾠproteomic	 ﾠdata	 ﾠto	 ﾠbetter	 ﾠelucidate	 ﾠdisease	 ﾠetiology.	 ﾠ
There	 ﾠare,	 ﾠhowever,	 ﾠother	 ﾠpotential	 ﾠapplications	 ﾠof	 ﾠa	 ﾠnetwork-ﾭ‐based	 ﾠapproach	 ﾠto	 ﾠdiseases.	 ﾠPhenotypic	 ﾠ
“maps”	 ﾠlike	 ﾠthe	 ﾠones	 ﾠpresented	 ﾠhere	 ﾠcould	 ﾠbe	 ﾠused	 ﾠto	 ﾠstudy	 ﾠthe	 ﾠdisease	 ﾠevolution	 ﾠof	 ﾠpatients	 ﾠand	 ﾠ
represent	 ﾠan	 ﾠideal	 ﾠway	 ﾠto	 ﾠvisualize	 ﾠand	 ﾠrepresent	 ﾠmedical	 ﾠhealth	 ﾠrecords	 ﾠin	 ﾠa	 ﾠfuture	 ﾠin	 ﾠwhich	 ﾠdigital	 ﾠ
medical	 ﾠrecords	 ﾠwill	 ﾠneed	 ﾠto	 ﾠbe	 ﾠaccessed	 ﾠby	 ﾠhealth	 ﾠcare	 ﾠworkers	 ﾠin	 ﾠa	 ﾠdelocalized	 ﾠmanner	 ﾠ[34].	 ﾠ
Here	 ﾠwe	 ﾠhave	 ﾠshown	 ﾠsuggestive	 ﾠevidence	 ﾠthat	 ﾠpatients	 ﾠdevelop	 ﾠdiseases	 ﾠclose	 ﾠin	 ﾠthe	 ﾠPDN	 ﾠto	 ﾠ
those	 ﾠalready	 ﾠaffecting	 ﾠthem.	 ﾠWe	 ﾠalso	 ﾠshowed	 ﾠthat	 ﾠthe	 ﾠPDN	 ﾠhas	 ﾠa	 ﾠheterogeneous	 ﾠstructure	 ﾠwhere	 ﾠsome	 ﾠ
diseases	 ﾠare	 ﾠhighly	 ﾠconnected	 ﾠwhile	 ﾠothers	 ﾠare	 ﾠbarely	 ﾠconnected	 ﾠat	 ﾠall.	 ﾠWhile	 ﾠnot	 ﾠconclusive,	 ﾠthese	 ﾠ
observations	 ﾠcan	 ﾠexplain	 ﾠthe	 ﾠobservation	 ﾠthat	 ﾠmore	 ﾠconnected	 ﾠdiseases	 ﾠare	 ﾠseen	 ﾠto	 ﾠbe	 ﾠmore	 ﾠlethal,	 ﾠas	 ﾠ
patients	 ﾠdeveloping	 ﾠhighly	 ﾠconnected	 ﾠdiseases	 ﾠare	 ﾠmore	 ﾠlikely	 ﾠthose	 ﾠat	 ﾠan	 ﾠadvanced	 ﾠstage	 ﾠof	 ﾠdisease,	 ﾠ
which	 ﾠcan	 ﾠbe	 ﾠreached	 ﾠthrough	 ﾠmultiple	 ﾠpaths	 ﾠin	 ﾠthe	 ﾠPDN.	 ﾠ	 ﾠ	 ﾠ
Exploring	 ﾠcomorbidities	 ﾠfrom	 ﾠa	 ﾠnetwork	 ﾠperspective	 ﾠcould	 ﾠhelp	 ﾠdetermine	 ﾠwhether	 ﾠdifferences	 ﾠ
in	 ﾠ the	 ﾠ comorbidity	 ﾠ patterns	 ﾠ expressed	 ﾠ in	 ﾠ different	 ﾠ populations	 ﾠ indicate	 ﾠ differences	 ﾠ in	 ﾠ biological	 ﾠ
processes,	 ﾠenvironmental	 ﾠfactors,	 ﾠor	 ﾠhealth	 ﾠcare	 ﾠquality	 ﾠprovided	 ﾠfor	 ﾠeach	 ﾠpopulation.	 ﾠHere	 ﾠwe	 ﾠshow	 ﾠas	 ﾠ18	 ﾠ
	 ﾠ
a	 ﾠfirst	 ﾠstep	 ﾠthat	 ﾠthere	 ﾠare	 ﾠdifferences	 ﾠin	 ﾠthe	 ﾠstrength	 ﾠof	 ﾠco-ﾭ‐morbidities	 ﾠmeasured	 ﾠfor	 ﾠpatients	 ﾠof	 ﾠdifferent	 ﾠ
races	 ﾠand	 ﾠgender.	 ﾠThe	 ﾠPDN	 ﾠcould	 ﾠbe	 ﾠthe	 ﾠstarting	 ﾠpoint	 ﾠof	 ﾠstudies	 ﾠexploring	 ﾠthese	 ﾠand	 ﾠrelated	 ﾠquestions.	 ﾠ
This	 ﾠis	 ﾠwhy	 ﾠwe	 ﾠmake	 ﾠour	 ﾠdata	 ﾠavailable	 ﾠto	 ﾠthe	 ﾠresearch	 ﾠcommunity	 ﾠat	 ﾠ(http://hudine.neu.edu)	 ﾠ
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Figure	 ﾠ 1	 ﾠ Data	 ﾠ characteristics	 ﾠ and	 ﾠ basic	 ﾠ comorbidity	 ﾠ statistics.	 ﾠ A	 ﾠA g e 	 ﾠd i s t r i b u t i o n 	 ﾠf o r 	 ﾠt h e 	 ﾠs t u d y 	 ﾠ
population.	 ﾠ B	 ﾠD e m o g r a p h i c 	 ﾠb r e a k d o w n 	 ﾠo f 	 ﾠt h e 	 ﾠs t u d y 	 ﾠp o p u l a t i o n . 	 ﾠC	 ﾠ Prevalence	 ﾠ distribution	 ﾠf o r 	 ﾠa l l 	 ﾠ
diseases	 ﾠmeasured	 ﾠusing	 ﾠICD9	 ﾠcodes	 ﾠat	 ﾠthe	 ﾠ5	 ﾠdigit	 ﾠlevel.	 ﾠD	 ﾠDistribution	 ﾠof	 ﾠthe	 ﾠrelative	 ﾠrisk	 ﾠ(RR)	 ﾠbetween	 ﾠ
all	 ﾠdisease	 ﾠpairs.	 ﾠE	 ﾠDistribution	 ﾠof	 ﾠthe	 ﾠφ-ﾭ‐correlation	 ﾠbetween	 ﾠall	 ﾠdisease	 ﾠpairs.	 ﾠF	 ﾠScatter	 ﾠplot	 ﾠbetween	 ﾠthe	 ﾠ




Figure	 ﾠ2.	 ﾠPhenotypic	 ﾠDisease	 ﾠNetworks	 ﾠ(PDNs).	 ﾠNodes	 ﾠare	 ﾠdiseases;	 ﾠlinks	 ﾠare	 ﾠcorrelations.	 ﾠNode	 ﾠcolor	 ﾠ
identifies	 ﾠ the	 ﾠ ICD9	 ﾠ category;	 ﾠ node	 ﾠ size	 ﾠ is	 ﾠ proportional	 ﾠ to	 ﾠ disease	 ﾠ prevalence.	 ﾠ Link	 ﾠ color	 ﾠ indicates	 ﾠ
correlation	 ﾠstrength.	 ﾠA	 ﾠPDN	 ﾠconstructed	 ﾠusing	 ﾠRR.	 ﾠOnly	 ﾠstatistically	 ﾠsignificant	 ﾠlinks	 ﾠwith	 ﾠRRij>	 ﾠ20	 ﾠare	 ﾠ




Figure	 ﾠ3	 ﾠThe	 ﾠPhenotypic	 ﾠDisease	 ﾠNetwork	 ﾠand	 ﾠdisease	 ﾠdynamics.	 ﾠA	 ﾠSchematic	 ﾠrepresentation	 ﾠof	 ﾠthe	 ﾠ
three	 ﾠdynamical	 ﾠquestions	 ﾠexplore	 ﾠhere.	 ﾠB	 ﾠAverage	 ﾠφ-ﾭ‐correlation	 ﾠbetween	 ﾠdiseases	 ﾠdiagnosed	 ﾠin	 ﾠthe	 ﾠfirst	 ﾠ
two	 ﾠand	 ﾠlast	 ﾠtwo	 ﾠvisits	 ﾠfor	 ﾠthe	 ﾠ946,580	 ﾠpatients	 ﾠwith	 ﾠ4	 ﾠvisits	 ﾠ(green)	 ﾠand	 ﾠwhen	 ﾠwe	 ﾠconsider	 ﾠa	 ﾠrandomized	 ﾠ
set	 ﾠof	 ﾠdiseases	 ﾠfor	 ﾠthe	 ﾠfirst	 ﾠtwo	 ﾠvisits	 ﾠ(red).	 ﾠC	 ﾠsame	 ﾠas	 ﾠB	 ﾠbut	 ﾠfor	 ﾠthe	 ﾠRR-ﾭ‐PDN.	 ﾠD.	 ﾠRatio	 ﾠbetween	 ﾠthe	 ﾠ
average	 ﾠφ-ﾭ‐correlation	 ﾠamong	 ﾠdiagnoses	 ﾠreceived	 ﾠby	 ﾠa	 ﾠpatient	 ﾠin	 ﾠits	 ﾠfirst	 ﾠtwo	 ﾠand	 ﾠlast	 ﾠtwo	 ﾠvisits	 ﾠrelative	 ﾠto	 ﾠ
the	 ﾠcontrol	 ﾠcase.	 ﾠE.	 ﾠsame	 ﾠas	 ﾠD	 ﾠbut	 ﾠfor	 ﾠthe	 ﾠRR-ﾭ‐PDN.	 ﾠF.	 ﾠGender	 ﾠand	 ﾠrace	 ﾠdifferences.	 ﾠThe	 ﾠsubset	 ﾠof	 ﾠFig	 ﾠ2	 ﾠB	 ﾠ
where	 ﾠall	 ﾠdiseases	 ﾠconnected	 ﾠto	 ﾠhypertension	 ﾠand	 ﾠischemic	 ﾠheart	 ﾠdisease	 ﾠis	 ﾠshown.	 ﾠBlue	 ﾠlinks	 ﾠindicate	 ﾠ
comorbidities	 ﾠthat	 ﾠare	 ﾠstrongest	 ﾠamong	 ﾠblack	 ﾠmales;	 ﾠwhereas	 ﾠred	 ﾠlinks	 ﾠindicate	 ﾠcomorbidities	 ﾠthat	 ﾠare	 ﾠ








Figure	 ﾠ4	 ﾠDisease	 ﾠconnectivity	 ﾠand	 ﾠlethality.	 ﾠA	 ﾠScatter	 ﾠplot	 ﾠbetween	 ﾠthe	 ﾠconnectivity	 ﾠof	 ﾠa	 ﾠdisease	 ﾠ
measured	 ﾠin	 ﾠthe	 ﾠφ-ﾭ‐PDN	 ﾠand	 ﾠthe	 ﾠpercent	 ﾠof	 ﾠpatients	 ﾠthat	 ﾠdied	 ﾠ8	 ﾠyears	 ﾠafter	 ﾠthis	 ﾠdisease	 ﾠwas	 ﾠfirst	 ﾠ
observed	 ﾠin	 ﾠour	 ﾠdata	 ﾠset.	 ﾠB	 ﾠSame	 ﾠas	 ﾠA	 ﾠfor	 ﾠthe	 ﾠRR-ﾭ‐PDN	 ﾠC	 ﾠpercent	 ﾠof	 ﾠpatients	 ﾠthat	 ﾠdied	 ﾠ8	 ﾠyears	 ﾠafter	 ﾠthis	 ﾠ
disease	 ﾠwas	 ﾠfirst	 ﾠobserved	 ﾠin	 ﾠour	 ﾠdata	 ﾠset	 ﾠas	 ﾠa	 ﾠfunction	 ﾠof	 ﾠdisease	 ﾠprevalence.	 ﾠD	 ﾠsame	 ﾠas	 ﾠA	 ﾠshowing	 ﾠonly	 ﾠ
neoplasms.	 ﾠE	 ﾠsame	 ﾠas	 ﾠB	 ﾠshowing	 ﾠonly	 ﾠneoplasms.	 ﾠF	 ﾠsame	 ﾠas	 ﾠA	 ﾠshowing	 ﾠonly	 ﾠmental	 ﾠdisorders.	 ﾠG	 ﾠsame	 ﾠas	 ﾠ




Figure	 ﾠ5	 ﾠConnectivity	 ﾠlethality	 ﾠcontrol.	 ﾠA.	 ﾠHistogram	 ﾠwith	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠvisits	 ﾠfor	 ﾠeach	 ﾠpatient	 ﾠfor	 ﾠwhich	 ﾠ
the	 ﾠyear	 ﾠof	 ﾠdeath	 ﾠis	 ﾠknown.	 ﾠB.	 ﾠHistogram	 ﾠfor	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠdiagnosis	 ﾠassigned	 ﾠto	 ﾠeach	 ﾠpatient	 ﾠfor	 ﾠwhich	 ﾠ
the	 ﾠyear	 ﾠof	 ﾠdeath	 ﾠis	 ﾠknown.	 ﾠC.	 ﾠCorrelation	 ﾠbetween	 ﾠthe	 ﾠaverage	 ﾠconnectivity	 ﾠof	 ﾠthe	 ﾠdiagnosis	 ﾠassigned	 ﾠto	 ﾠ
a	 ﾠpatient	 ﾠand	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠyears	 ﾠsurvived	 ﾠafter	 ﾠthe	 ﾠlast	 ﾠdiagnosis	 ﾠwas	 ﾠrecorded	 ﾠfor	 ﾠgroups	 ﾠof	 ﾠpatients	 ﾠ
with	 ﾠ the	 ﾠ same	 ﾠ number	 ﾠ of	 ﾠ hospital	 ﾠ visits.	 ﾠ D.	 ﾠC o r r e l a t i o n 	 ﾠb e t w e e n 	 ﾠt h e 	 ﾠa v e r a g e 	 ﾠc o n n e c t i v i t y 	 ﾠo f 	 ﾠt h e 	 ﾠ
diagnosis	 ﾠassigned	 ﾠto	 ﾠa	 ﾠpatient	 ﾠand	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠyears	 ﾠsurvived	 ﾠafter	 ﾠthe	 ﾠlast	 ﾠdiagnosis	 ﾠwas	 ﾠrecorded	 ﾠ
for	 ﾠgroups	 ﾠof	 ﾠpatients	 ﾠwith	 ﾠthe	 ﾠsame	 ﾠnumber	 ﾠof	 ﾠtotal	 ﾠnumber	 ﾠof	 ﾠdiagnosis	 ﾠassigned.	 ﾠError	 ﾠmargins	 ﾠin	 ﾠC	 ﾠ
and	 ﾠD	 ﾠrepresent	 ﾠ95%	 ﾠconfidence	 ﾠintervals.	 ﾠ26	 ﾠ
	 ﾠ
	 ﾠ
Figure	 ﾠ6	 ﾠDirectionality	 ﾠof	 ﾠdisease	 ﾠprogression.	 ﾠA.	 ﾠDistribution	 ﾠof	 ﾠλ1-ﾭ‐>2	 ﾠB.	 ﾠDisease	 ﾠprecedence	 ﾠΛi	 ﾠas	 ﾠa	 ﾠ
function	 ﾠof	 ﾠdisease	 ﾠprevalence	 ﾠPi.	 ﾠThe	 ﾠinset	 ﾠshows	 ﾠthe	 ﾠsame	 ﾠplot	 ﾠafter	 ﾠremoving	 ﾠthe	 ﾠtrend	 ﾠfrom	 ﾠdisease	 ﾠ
precedence	 ﾠ(Λi*= ΛI	 ﾠ+	 ﾠ496.08log 10(Pi)-ﾭ‐2446.2)	 ﾠC.	 ﾠDisease	 ﾠconnectivity	 ﾠcalculated	 ﾠfrom	 ﾠthe	 ﾠφ-ﾭ‐PDN	 ﾠas	 ﾠa	 ﾠ
function	 ﾠof	 ﾠΛi*.	 ﾠThe	 ﾠgreen	 ﾠline	 ﾠshows	 ﾠthe	 ﾠbest	 ﾠfit	 ﾠfor	 ﾠthe	 ﾠ518	 ﾠdiseases	 ﾠwith	 ﾠa	 ﾠprevalence	 ﾠlarger	 ﾠthan	 ﾠ
1/500	 ﾠ(green	 ﾠcircles)	 ﾠwhile	 ﾠthe	 ﾠred	 ﾠline	 ﾠshows	 ﾠthe	 ﾠbest	 ﾠfit	 ﾠfor	 ﾠthe	 ﾠ463	 ﾠdiseases	 ﾠat	 ﾠthe	 ﾠcenter	 ﾠof	 ﾠthe	 ﾠcloud	 ﾠ
(red	 ﾠ points).	 ﾠ The	 ﾠ correlation	 ﾠ coefficient	 ﾠ is	 ﾠ represented	 ﾠ by	 ﾠ r	 ﾠa n d 	 ﾠi t s 	 ﾠa s s o c i a t e d 	 ﾠp -ﾭ‐value	 ﾠ by	 ﾠ p.	 ﾠ D.	 ﾠ
Percentage	 ﾠ of	 ﾠ patients	 ﾠ that	 ﾠ died	 ﾠ 2	 ﾠ and	 ﾠ 8	 ﾠ years	 ﾠ after	 ﾠ being	 ﾠ diagnosed	 ﾠ with	 ﾠ a	 ﾠ disease	 ﾠ with	 ﾠ a	 ﾠ given	 ﾠ
detrended	 ﾠprecedence	 ﾠΛi*.	 ﾠThe	 ﾠgreen	 ﾠlines	 ﾠshow	 ﾠthe	 ﾠbest	 ﾠfit	 ﾠfor	 ﾠall	 ﾠthe	 ﾠ518	 ﾠdiseases	 ﾠ(green	 ﾠcircles)	 ﾠwhile	 ﾠ
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